{"gene":"LRPPRC","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":2024,"finding":"Cryo-EM structure of LRPPRC-SLIRP complex bound to mRNA and the mitoribosome shows that LRPPRC associates with mitoribosomal proteins mS39 and the N-terminus of mS31 through its helical (PPR) repeats, forming a corridor for mRNA handoff to the ribosome; SLIRP directly binds the mRNA and stabilizes LRPPRC within the complex. RNA sequencing, metabolic labeling, and ribosome profiling show transcript-specific effects on translation efficiency, with COX1 and COX2 translation most affected.","method":"Cryo-electron microscopy structure determination, RNA sequencing, metabolic labeling, mitoribosome profiling","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — cryo-EM structure with multiple orthogonal functional validation methods (metabolic labeling, ribosome profiling, RNA-seq) in a single rigorous study","pmids":["39134711"],"is_preprint":false},{"year":2017,"finding":"LRPPRC in complex with SLIRP acts as a global RNA chaperone throughout the mitochondrial transcriptome, stabilizing RNA secondary structures to expose sites required for translation, stabilization, and polyadenylation. RNase footprinting combined with PAR-CLIP showed LRPPRC-SLIRP binds preferentially to mRNAs, and its loss alters the entire secondary structure and stability of the mitochondrial transcriptome.","method":"RNase footprinting, PAR-CLIP (photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation)","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — two orthogonal high-throughput RNA-protein mapping methods (PAR-CLIP + RNase footprinting) at unprecedented depth in a single study","pmids":["29146908"],"is_preprint":false},{"year":2016,"finding":"LRPPRC-SLIRP form a heterodimer via interactions between polar amino acids in the single RRM domain of SLIRP and three neighboring PPR motifs in the second quarter of LRPPRC. Specific residues at this interface, predicted to bind RNA in LRPPRC and located in the RNP1 motif of SLIRP's RRM, are instead used for protein-protein interaction, enabling stable complex formation. In vitro binding assays showed LRPPRC has broad RNA-binding capacity while SLIRP associates only weakly with RNA.","method":"In vitro RNA-binding assays, mutagenesis of interaction interface, biochemical characterization of LRPPRC-SLIRP complex","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro reconstitution with mutagenesis, single lab with multiple orthogonal methods","pmids":["27353330"],"is_preprint":false},{"year":2011,"finding":"Tissue-specific knockout of Lrpprc in mouse heart causes drastic reduction in steady-state levels of most mitochondrial mRNAs, loss of mRNA polyadenylation, and aberrant mitochondrial translation with excessive translation of some transcripts and absent translation of others. LRPPRC forms an RNA-dependent protein complex necessary for maintaining a pool of non-translated mRNAs.","method":"Conditional knockout mouse model, Northern blot, mitochondrial translation assay, protein complex analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean conditional KO with multiple defined molecular phenotypes (mRNA stability, polyadenylation, translation), replicated across tissues","pmids":["22045337"],"is_preprint":false},{"year":2012,"finding":"The LRPPRC/SLIRP complex suppresses 3' exonucleolytic mRNA degradation mediated by PNPase and SUV3 and cotranscriptionally binds coding sequences of mitochondrial mRNAs. In vitro, LRPPRC promoted polyadenylation of mRNAs mediated by mitochondrial poly(A) polymerase (MTPAP).","method":"In vitro polyadenylation assay with MTPAP, RNA degradation assay with PNPase/SUV3, RNA immunoprecipitation, absolute quantification of mitochondrial mRNAs","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro reconstitution of polyadenylation and degradation suppression activities, multiple orthogonal methods, single lab","pmids":["22661577"],"is_preprint":false},{"year":2015,"finding":"SLIRP stabilizes LRPPRC by protecting it from degradation; LRPPRC is partially degraded when the LRPPRC-SLIRP complex is disrupted. SLIRP is required for proper association of mRNAs with the mitochondrial ribosome and efficient translation, but is dispensable for mRNA polyadenylation. Slirp knockout mice show 50–70% reduction in mtDNA-encoded mRNAs despite being apparently healthy.","method":"Slirp knockout mice, deep RNA sequencing of mitochondrial ribosomal fractions, molecular analyses of polyadenylation and translation","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo KO model with multiple orthogonal molecular readouts (ribosome-associated RNA-seq, polyadenylation analysis, protein stability assays)","pmids":["26247782"],"is_preprint":false},{"year":2003,"finding":"LRP130/LRPPRC is directly bound in vivo to mitochondrial polyadenylated RNAs and to nuclear mRNAs also associated with hnRNP A1. In vitro, LRP130 binds preferentially to polypyrimidines, with RNA-binding activity mapping to a C-terminal domain containing only 2 of 11 predicted PPR motifs — a novel non-canonical RNA-binding domain. The majority of LRP130 is localized within mitochondria.","method":"In vivo RNA crosslinking/immunoprecipitation, in vitro RNA-binding assays, subcellular fractionation, domain mapping","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo crosslinking combined with in vitro domain mapping, first identification of mitochondrial RNA binding, multiple orthogonal methods","pmids":["12832482"],"is_preprint":false},{"year":2013,"finding":"LRPPRC does not activate mitochondrial transcription. Size exclusion chromatography and immunoprecipitation in human cell lines and mice found no interaction between LRPPRC and the mitochondrial RNA polymerase POLRMT. Addition of purified LRPPRC to a recombinant in vitro transcription system did not activate mtDNA transcription. Variation of LRPPRC levels in vivo affected unprocessed precursor transcript levels but not steady-state mRNA levels or de novo transcription.","method":"Size exclusion chromatography, co-immunoprecipitation, in vitro transcription reconstitution, BAC transgenic mice, heterozygous knockout mice","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro reconstitution showing no transcriptional activation, negative co-IP replicated in multiple systems, in vivo transgenic models; this is a rigorously established negative result","pmids":["23599432"],"is_preprint":false},{"year":2010,"finding":"LRPPRC is exclusively localized to the mitochondrial matrix in mammalian cells; a single protein isoform exists, its mitochondrial targeting sequence is cleaved upon import, and orthologs are restricted to metazoans with conserved mitochondrial targeting signals.","method":"Subcellular fractionation, bioinformatic analysis of targeting sequences, direct protein localization experiments in mammalian cells","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct fractionation experiments plus bioinformatics, single lab, two complementary methods","pmids":["20633537"],"is_preprint":false},{"year":2006,"finding":"LRP130/LRPPRC is a component of the PGC-1α transcriptional coactivator complex and is required for PGC-1α-dependent expression of gluconeogenic genes PEPCK and G6P, as well as certain mitochondrial genes. Adenoviral RNAi knockdown of LRP130 in fasted mice blocked PEPCK and G6P induction and blunted hepatic glucose output.","method":"Co-purification/mass spectrometry identification of PGC-1α complex components, adenoviral RNAi in mice, gene expression analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo RNAi with defined metabolic phenotype plus biochemical identification of complex, multiple orthogonal methods","pmids":["17050673"],"is_preprint":false},{"year":2011,"finding":"LRP130/LRPPRC complexes with the mitochondrial RNA polymerase (POLRMT) to activate mitochondrial transcription (as assessed by convergent genetic and biochemical approaches), which is associated with increased OXPHOS activity, increased supercomplex formation, denser cristae, and increased hepatic β-fatty acid oxidation.","method":"Co-immunoprecipitation, genetic overexpression, biochemical OXPHOS activity assays, fatty acid oxidation assay with 14C-palmitate","journal":"The Journal of biological chemistry","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP claim for POLRMT interaction contradicted by a more rigorous study (PMID:23599432) using in vitro reconstitution and multiple Co-IP approaches that found no interaction; confidence accordingly low","pmids":["21971050"],"is_preprint":false},{"year":2014,"finding":"Loss of LRPPRC in conditional knockout mouse hearts causes ATP synthase deficiency rather than solely COX deficiency; inactive subassembled ATP synthase complexes accumulate, causing mitochondrial hyperpolarization and increased reactive oxygen species production.","method":"Conditional Lrpprc knockout mouse hearts, OXPHOS complex activity assays, mitochondrial membrane potential measurement, ROS measurement","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean conditional KO with multiple defined biochemical phenotypes, in vivo mouse model","pmids":["24399447"],"is_preprint":false},{"year":2004,"finding":"LRPPRC protein levels are reduced to <30% of control in fibroblast and liver mitochondria from LSFC patients carrying the A354V mutation. Reduced LRPPRC results in decreased COX I and COX III mRNA levels and specifically reduced translation of COX I. Import of the mutant A354V LRPPRC into rat liver mitochondria is slower than wild-type.","method":"Northern blot for mitochondrial mRNAs, [35S]methionine mitochondrial translation labeling, mitochondrial import assay, immunofluorescence","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (mRNA, translation, import assays) in patient cells, single lab","pmids":["15139850"],"is_preprint":false},{"year":2012,"finding":"LRPPRC requires its first 19 PPR motifs for full binding to COX I mRNA; a specific segment of COX I mRNA encoded by mouse mtDNA nucleotides 5961–6020 was identified as the binding target. Homozygous LRPPRC C-terminus truncation causes embryonic lethality and major decrease in COX activity in mouse embryonic fibroblasts.","method":"Recombinant protein expression with PPR domain truncations, in vitro RNA-binding assay, gene-trap mouse model, COX activity assay","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — in vitro domain mapping with recombinant proteins plus in vivo knockout, single lab","pmids":["21880015"],"is_preprint":false},{"year":2013,"finding":"Reducing mma-1/LRPPRC function in C. elegans and mammalian cells causes mitochondrial hyperfusion as a compensatory response to decreased complex IV activity. Preventing mitochondrial hyperfusion in mma-1 animals causes larval arrest and embryonic lethality. Prolonged LRPPRC knockdown in mammalian cells leads to subsequent mitochondrial fragmentation and decreased ATP.","method":"C. elegans mma-1 mutants and mammalian LRPPRC knockdown, live-cell mitochondrial morphology imaging, genetic epistasis, ATP measurement","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — epistasis experiments in two organisms (C. elegans and mammalian cells), live imaging, defined physiological phenotype","pmids":["23878239"],"is_preprint":false},{"year":2013,"finding":"LRPPRC interacts with Beclin 1 and Bcl-2 to form a ternary complex that maintains Bcl-2 stability. Suppression of LRPPRC reduces mitochondrial membrane potential and Bcl-2 levels, releasing Beclin 1 to activate the PI3K/Akt/mTOR autophagy pathway, thereby initiating basal autophagy and mitochondrial turnover.","method":"Co-immunoprecipitation, GFP-LC3 puncta assay, LC3-II/p62 western blot, siRNA knockdown in multiple cell lines, mitochondrial membrane potential assay","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — reciprocal Co-IP with functional KD phenotype, single lab, multiple cell lines and markers","pmids":["23822101"],"is_preprint":false},{"year":2014,"finding":"Under mitophagy stress, Parkin translocates to mitochondria and binds to exposed LRPPRC on the outer mitochondrial membrane. LRPPRC maintains Parkin stability (Parkin mono-ubiquitinates Bcl-2 to increase its stability and inhibit autophagy). LRPPRC and Parkin together facilitate engulfment of mitochondria into autophagosomes.","method":"Co-immunoprecipitation, subcellular fractionation, CCCP-induced mitophagy, western blot for Parkin/Bcl-2/LC3 markers","journal":"PloS one","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP/pulldown approach, single lab, interaction under stress conditions only partially validated","pmids":["24722279"],"is_preprint":false},{"year":2015,"finding":"LRPPRC knockdown in mammalian cells causes an imbalance between mitochondria-encoded and nuclear-encoded complex IV subunits that triggers the mitochondrial unfolded protein response (UPRmt). Inactivation of LRPPRC homolog mma-1 in C. elegans also induces UPRmt, demonstrating evolutionary conservation. Mitochondrial hyperfusion and UPRmt are coordinated but mediated by genetically distinct pathways.","method":"siRNA knockdown in mammalian cells, C. elegans mma-1 mutants, UPRmt reporter assays, genetic epistasis","journal":"Aging","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in two organisms, UPRmt reporter assay, single lab","pmids":["26412102"],"is_preprint":false},{"year":2004,"finding":"LRP130/LRPPRC binds to a 12 bp invMED1 cis-activating element in the MDR1 gene promoter as a nuclear factor, and its binding intensity correlates with MDR1 expression level. LRP130 regulates transcriptional activity of both MDR1 and MVP gene promoters, as demonstrated by siRNA and transcriptional decoys.","method":"Electrophoretic mobility shift assay, siRNA knockdown, transcriptional decoys, luciferase reporter assay, chromatin immunoprecipitation","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus functional reporter assay and siRNA in multiple cell lines, single lab","pmids":["15272088"],"is_preprint":false},{"year":2008,"finding":"LRP130 is a binding partner of PGC-1α in brown adipocytes, is preferentially enriched in brown fat, and is required for PGC-1α-dependent expression of UCP1 and other brown fat genes. Brown fat cells deficient for LRP130 exhibit reduced proton leak due to attenuated UCP1 expression.","method":"Co-immunoprecipitation, LRP130 knockdown in brown adipocytes, oxygen consumption assay, gene expression analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with functional KD, oxygen consumption readout, single lab","pmids":["18728005"],"is_preprint":false},{"year":2018,"finding":"LRPPRC acts as a negative regulator of MAVS-mediated antiviral signaling by interacting with MAVS and inhibiting its association with TRAF3 and TRAF6. LRPPRC knockdown results in inhibition of HCV infection associated with increased IFN response activation. The HCV NS5A protein exploits LRPPRC to interfere with MAVS activity in a LRPPRC-dependent manner.","method":"Co-immunoprecipitation (LRPPRC-MAVS, MAVS-TRAF3, MAVS-TRAF6), siRNA knockdown, HCV infection assay, IFN response measurement","journal":"Hepatology (Baltimore, Md.)","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — reciprocal Co-IP in multiple combinations, functional knockdown phenotype, single lab","pmids":["30070380"],"is_preprint":false},{"year":2024,"finding":"SIRT3 binds to and deacetylates LRPPRC, and this deacetylation modulates mitochondrial function (oxidative phosphorylation and oxidative stress) and cellular senescence. LRPPRC in turn regulates senescence by modulating OXPHOS and oxidative stress.","method":"Co-immunoprecipitation, western blot with acetylation antibodies, SIRT3 overexpression/knockdown, in vitro and in vivo senescence assays","journal":"Free radical biology & medicine","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP plus phenotypic assays, single lab, no deacetylation site mapped by mutagenesis in the abstract","pmids":["39557134"],"is_preprint":false},{"year":2022,"finding":"LRPPRC specifically binds to MDR1 mRNA and increases its stability and protein expression. P53-induced miR-34a suppresses LRPPRC expression; when P53 is mutated, accumulated LRPPRC stabilizes MDR1 mRNA, promoting chemoresistance. Gossypol-acetic acid (GAA) induces degradation of LRPPRC protein and reduces chemoresistance.","method":"RNA immunoprecipitation (RIP), mRNA stability assay, miR-34a reporter assay, GAA treatment with western blot and proliferation assays, in vivo xenograft","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RIP demonstrating direct LRPPRC-MDR1 mRNA binding, mRNA stability assay, in vivo validation, single lab","pmids":["35484333"],"is_preprint":false},{"year":2023,"finding":"LRPPRC promotes the synthesis of OXPHOS subunits by binding to RNAs encoded by mitochondrial DNA. Gossypol acetic acid (GAA) binds directly to LRPPRC and induces its rapid degradation in a ubiquitin-independent manner, suppressing OXPHOS complex synthesis.","method":"RNA binding pulldown, LC-MS target identification, GAA direct binding assay, ubiquitination assay, OXPHOS subunit expression analysis, xenograft","journal":"Journal of translational medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding assay for GAA-LRPPRC, multiple orthogonal methods, single lab","pmids":["37496051"],"is_preprint":false},{"year":2023,"finding":"LRPPRC promotes CDK4/6 inhibitor resistance in lung cancer by binding to CDK6 mRNA and increasing CDK6 mRNA stability and protein expression. CDK6 downstream effector E2F1 binds the LRPPRC promoter, forming a feedback loop; this LRPPRC-CDK6 loop facilitates G1/S transition, OXPHOS, and cancer stem cell generation.","method":"RNA immunoprecipitation (RIP) for LRPPRC-CDK6 mRNA, mRNA stability assay, promoter binding (ChIP), CDK4/6 inhibitor resistance assays in vitro and in vivo","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RIP confirming direct mRNA binding, ChIP for promoter interaction, in vivo validation, single lab","pmids":["37452037"],"is_preprint":false},{"year":2021,"finding":"SNHG17 lncRNA physically interacts with the 1035–1369 aa domain of LRPPRC protein; this interaction is required for LRPPRC to inhibit c-Myc ubiquitination and promote c-Myc stability, G1/S transition, and cell proliferation.","method":"RNA pull-down, co-immunoprecipitation, c-Myc ubiquitination assay, domain mapping, rescue experiments with LRPPRC/SNHG17 silencing","journal":"Cell death & disease","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, RNA pulldown and Co-IP but domain mapping only by deletion not mutagenesis; mechanism of LRPPRC-mediated c-Myc deubiquitination not fully resolved","pmids":["34671012"],"is_preprint":false},{"year":2024,"finding":"LRPPRC acts as an m6A reader that binds m6A-modified PD-L1 mRNA and stabilizes it posttranscriptionally in an m6A-dependent manner, increasing PD-L1 expression. LRPPRC loss downregulates PD-L1 and its m6A level in HCC cells and improves anti-tumor immunity in murine models.","method":"RNA immunoprecipitation (RIP), methylated RNA immunoprecipitation (MeRIP-qPCR), RNA stability assay, LRPPRC knockout in HCC cells and mouse models","journal":"Frontiers in immunology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — RIP and MeRIP support m6A-binding, single lab, abstract does not describe mutagenesis of m6A sites to rigorously confirm reader function","pmids":["37063837"],"is_preprint":false},{"year":2024,"finding":"LRPPRC recognizes m6A modification sites on LDHA mRNA and enhances LDHA mRNA stability, promoting glycolysis in triple-negative breast cancer. LRPPRC knockdown reduces glycolysis and increases glutaminolysis; combined LRPPRC knockdown plus glutaminase inhibition induces synthetic lethality.","method":"MeRIP-sequencing, RNA immunoprecipitation (RIP), RNA pull-down, RNA stability assay, Seahorse metabolic assay, patient-derived xenografts and organoids","journal":"Clinical and translational medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — MeRIP-seq plus RIP/pulldown confirming direct m6A-dependent LDHA mRNA binding, multiple orthogonal metabolic readouts, single lab","pmids":["38372449"],"is_preprint":false},{"year":2024,"finding":"The LRPPRC-SLIRP complex is required for maintaining normal complex I levels in vivo; disruption of complex formation by knock-in mutations causes partial LRPPRC degradation and disappearance of SLIRP. The complex coordinates mitochondrial translation in a tissue-specific manner, and introducing an additive mtDNA mutation (m.C5024T tRNA-Ala) into Slirp knockout mice causes embryonic lethality through additive translation defects.","method":"Knock-in mice with LRPPRC-SLIRP interface mutations, SLIRP knockout mice, mitochondrial translation assays, complex I activity measurement, genetic epistasis with mtDNA mutation","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo knock-in and double-mutant genetic epistasis across two organisms/mutations, multiple molecular phenotypes","pmids":["39087558"],"is_preprint":false},{"year":2025,"finding":"USP44 recruits and stabilizes E3 ubiquitin ligase STUB1 by removing its K48-linked polyubiquitin chains at Lys30. STUB1 in turn promotes K48-linked polyubiquitination of LRPPRC at Lys453, leading to LRPPRC protein degradation and accumulation of mitochondrial ROS, facilitating apoptosis and cisplatin sensitivity in neuroblastoma.","method":"Co-immunoprecipitation, ubiquitination site mapping (K453), mass spectrometry, overexpression and knockdown with rescue experiments, in vivo tumor models","journal":"Neuro-oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — specific K453 ubiquitination site identified on LRPPRC, multiple Co-IP/rescue experiments, single lab","pmids":["39215663"],"is_preprint":false},{"year":2022,"finding":"PSMD14 deubiquitinase directly interacts with LRPPRC and inhibits its ubiquitination, thereby stabilizing LRPPRC protein. This LRPPRC stabilization inhibits autophagy through the LRPPRC/Beclin1-Bcl-2/SQSTM1 signaling pathway, promoting ovarian cancer progression.","method":"Co-immunoprecipitation, ubiquitination assay, PSMD14 knockdown/overexpression, in vivo tumor growth and metastasis assay","journal":"Biochimica et biophysica acta. Molecular basis of disease","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP, single lab, no specific ubiquitination sites mapped in abstract","pmids":["36328147"],"is_preprint":false},{"year":2023,"finding":"In Drosophila, loss of lrpprc2 activates the PINK1-Park (Parkin) pathway, which regulates mitochondrial dynamics by inducing degradation of the mitochondrial fusion protein Mitofusin/Marf, rather than canonical mitophagy. Bendless (a K63-linked E2 conjugase) is required for PINK1 stability and for PINK1-Park-mediated Marf degradation; loss of Bendless in lrpprc2 mutants causes photoreceptor degeneration.","method":"Unbiased genetic screen in Drosophila, lrpprc2 mutant analysis, epistasis experiments with PINK1/Park/Bendless, Mitofusin/Marf protein level assays","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic screen with epistasis in Drosophila (ortholog), multiple pathway placement experiments, single lab","pmids":["37098042"],"is_preprint":false},{"year":2020,"finding":"LRP130/LRPPRC acts as a scaffold component of a transcriptional repressor complex with PGC1α; the lncRNA GUARDIN stabilizes LRP130/PGC1α heterodimers and their occupancy at the FOXO4 promoter. Silencing LRP130 or PGC1α leads to increased FOXO4 expression, upregulation of p21, and cellular senescence.","method":"Co-immunoprecipitation of LRP130-PGC1α complex, chromatin immunoprecipitation at FOXO4 promoter, siRNA knockdown, senescence assays","journal":"EMBO reports","confidence":"Low","confidence_rationale":"Tier 3 / Weak — Co-IP and ChIP supporting complex occupancy, but mechanistic detail of how LRP130 suppresses FOXO4 transcription is limited in the abstract","pmids":["32149459"],"is_preprint":false}],"current_model":"LRPPRC (LRP130) is a mitochondrial matrix PPR-family RNA-binding protein that, in stable complex with SLIRP, functions as a global RNA chaperone stabilizing mitochondrial mRNA secondary structures, suppressing PNPase-mediated mRNA degradation, promoting MTPAP-mediated polyadenylation, and delivering mRNAs to the mitoribosome (via contacts with mS39/mS31) for translation; loss of LRPPRC causes widespread mitochondrial mRNA destabilization, loss of polyadenylation, dyscoordinated translation of OXPHOS subunits (particularly COX1/2), ATP synthase deficiency, and compensatory mitochondrial hyperfusion and UPRmt, while outside the mitochondria LRPPRC also participates in PGC-1α-dependent nuclear transcription and, as an m6A reader, regulates stability of cytoplasmic mRNAs including MDR1 and PD-L1."},"narrative":{"mechanistic_narrative":"LRPPRC (LRP130) is a metazoan-conserved, mitochondrial matrix PPR-family RNA-binding protein that governs the post-transcriptional fate of the mitochondrial transcriptome [PMID:12832482, PMID:20633537]. Acting as a stable heterodimer with SLIRP—formed through interaction between SLIRP's RRM domain and three PPR motifs in LRPPRC, with SLIRP reciprocally protecting LRPPRC from degradation [PMID:27353330, PMID:26247782]—the complex functions as a global RNA chaperone that binds mitochondrial mRNA coding sequences and remodels their secondary structure to expose sites for stabilization, polyadenylation, and translation [PMID:29146908, PMID:22661577]. Mechanistically, LRPPRC-SLIRP suppresses PNPase/SUV3-mediated 3' exonucleolytic decay and promotes MTPAP-dependent polyadenylation [PMID:22661577], and the cryo-EM structure shows LRPPRC docking onto mitoribosomal proteins mS39 and mS31 to form a corridor that hands mRNA off to the ribosome, with COX1 and COX2 translation most dependent on this activity [PMID:39134711, PMID:21880015]. LRPPRC does not activate mitochondrial transcription [PMID:23599432]. Loss of LRPPRC destabilizes most mtDNA-encoded mRNAs, abolishes polyadenylation, and dyscoordinates OXPHOS subunit translation, producing complex IV and ATP synthase deficiency, mitochondrial hyperpolarization and ROS, and an evolutionarily conserved compensatory program of mitochondrial hyperfusion and the mitochondrial unfolded protein response [PMID:22045337, PMID:24399447, PMID:23878239, PMID:26412102]. The A354V hypomorphic mutation underlies Leigh syndrome French-Canadian type (LSFC), reducing LRPPRC levels and selectively impairing COX I mRNA stability and translation [PMID:15139850]. Outside the matrix, LRPPRC associates with PGC-1α as a transcriptional coactivator required for gluconeogenic and brown-fat thermogenic gene programs [PMID:17050673, PMID:18728005], and acts as a cytoplasmic m6A reader and mRNA-stabilizing factor whose targets include MDR1, CDK6, PD-L1, and LDHA, linking it to chemoresistance, cell-cycle progression, immune evasion, and glycolytic metabolism in cancer [PMID:35484333, PMID:37452037, PMID:37063837, PMID:38372449].","teleology":[{"year":2003,"claim":"Established that LRPPRC is a bona fide RNA-binding protein localized predominantly to mitochondria, binding mitochondrial polyadenylated RNAs through a non-canonical PPR-containing domain, redirecting attention from a presumed nuclear role to mitochondrial RNA metabolism.","evidence":"In vivo RNA crosslinking/IP, in vitro RNA-binding assays, subcellular fractionation, and domain mapping","pmids":["12832482"],"confidence":"High","gaps":["Did not define which mitochondrial transcripts are functionally regulated","RNA-binding domain mapping did not resolve the full PPR architecture's contribution"]},{"year":2004,"claim":"Linked LRPPRC to human disease by showing the LSFC A354V mutation reduces LRPPRC levels and selectively impairs COX I mRNA stability and translation, establishing a causal mechanism for the cytochrome c oxidase deficiency.","evidence":"Northern blot, [35S]methionine mitochondrial translation labeling, and import assays in LSFC patient cells","pmids":["15139850"],"confidence":"Medium","gaps":["Did not explain transcript selectivity for COX I","Mechanism connecting reduced protein to translation defect unresolved"]},{"year":2004,"claim":"Identified a nuclear, sequence-specific transcriptional activity of LRP130 on the MDR1 and MVP promoters, the first evidence of an extramitochondrial gene-regulatory role.","evidence":"EMSA, ChIP, luciferase reporters, and siRNA/transcriptional decoys in cell lines","pmids":["15272088"],"confidence":"Medium","gaps":["Did not reconcile nuclear function with predominantly mitochondrial localization","Direct DNA-binding versus cofactor recruitment not distinguished"]},{"year":2006,"claim":"Placed LRP130 within the PGC-1α coactivator complex and showed it is required for gluconeogenic gene induction and hepatic glucose output, defining a role in metabolic transcriptional programs.","evidence":"Co-purification/MS of the PGC-1α complex and adenoviral RNAi in fasted mice","pmids":["17050673"],"confidence":"High","gaps":["Did not clarify whether this is a direct DNA-associated function or indirect","Relationship to the mitochondrial RNA function unaddressed"]},{"year":2008,"claim":"Extended the PGC-1α partnership to brown adipose tissue, showing LRP130 is required for UCP1 expression and thermogenic proton leak.","evidence":"Co-IP, knockdown in brown adipocytes, and oxygen consumption assays","pmids":["18728005"],"confidence":"Medium","gaps":["Direct versus indirect transcriptional contribution not resolved","Tissue specificity mechanism unknown"]},{"year":2010,"claim":"Settled the localization debate by demonstrating LRPPRC is exclusively a mitochondrial matrix protein with a cleaved targeting sequence, constraining models of its nuclear/cytoplasmic functions.","evidence":"Subcellular fractionation and targeting-sequence bioinformatics in mammalian cells","pmids":["20633537"],"confidence":"Medium","gaps":["Apparent conflict with reported nuclear roles not reconciled","Single-isoform claim limits explanation of dual localization"]},{"year":2011,"claim":"Defined the core mitochondrial phenotype in vivo: LRPPRC loss collapses steady-state mRNA levels, abolishes polyadenylation, and dyscoordinates translation, establishing it as a master post-transcriptional regulator maintaining a non-translated mRNA pool.","evidence":"Conditional Lrpprc knockout mouse heart with Northern blot, translation assays, and complex analysis","pmids":["22045337"],"confidence":"High","gaps":["Did not resolve molecular activities (chaperone vs. polyadenylation vs. ribosome delivery)","Did not identify the partner stabilizing the complex"]},{"year":2011,"claim":"Proposed that LRPPRC complexes with POLRMT to activate mitochondrial transcription, an interpretation later contradicted by more rigorous reconstitution.","evidence":"Single Co-IP, overexpression, and OXPHOS/fatty-acid oxidation assays","pmids":["21971050"],"confidence":"Low","gaps":["POLRMT interaction not confirmed and directly contradicted by PMID 23599432","No in vitro reconstitution of transcriptional activation"]},{"year":2012,"claim":"Mapped two mechanistic activities of the LRPPRC/SLIRP complex—suppression of PNPase/SUV3 degradation and promotion of MTPAP polyadenylation—explaining how it stabilizes mitochondrial mRNAs; a parallel study mapped COX I mRNA binding to the first 19 PPR motifs.","evidence":"In vitro polyadenylation and degradation assays, RIP, and PPR-truncation RNA-binding assays with a gene-trap mouse","pmids":["22661577","21880015"],"confidence":"High","gaps":["Did not show how the same complex coordinates degradation suppression with translation","Structural basis of mRNA handoff to the ribosome not resolved"]},{"year":2013,"claim":"Rigorously excluded a transcriptional-activation role inside mitochondria, showing no POLRMT interaction and no activation of in vitro transcription, refocusing the field on post-transcriptional function.","evidence":"Size-exclusion chromatography, multiple Co-IPs, in vitro transcription reconstitution, and transgenic/heterozygous KO mice","pmids":["23599432"],"confidence":"High","gaps":["Effect on precursor transcripts not mechanistically explained","Did not address the separate nuclear PGC-1α transcriptional role"]},{"year":2013,"claim":"Revealed conserved organellar consequences of LRPPRC loss—mitochondrial hyperfusion as a protective response to low complex IV activity—linking the molecular defect to mitochondrial dynamics.","evidence":"C. elegans mma-1 mutants and mammalian knockdown with live imaging, epistasis, and ATP measurement","pmids":["23878239"],"confidence":"High","gaps":["Signaling pathway connecting OXPHOS deficiency to fusion machinery not defined","Whether hyperfusion is adaptive in mammals long-term unclear"]},{"year":2013,"claim":"Reported extramitochondrial roles in autophagy control via a LRPPRC-Beclin1-Bcl-2 ternary complex, suggesting LRPPRC restrains basal autophagy.","evidence":"Reciprocal Co-IP, GFP-LC3 puncta, LC3-II/p62 westerns, and siRNA in multiple lines","pmids":["23822101"],"confidence":"Medium","gaps":["How a matrix protein engages cytosolic Beclin1/Bcl-2 unresolved","Direct versus membrane-potential-dependent effect not separated"]},{"year":2014,"claim":"Broadened the OXPHOS phenotype beyond COX to ATP synthase deficiency with subassembled complexes, hyperpolarization, and ROS, refining the bioenergetic pathology of LRPPRC loss.","evidence":"Conditional Lrpprc KO mouse heart with OXPHOS activity, membrane potential, and ROS measurements","pmids":["24399447"],"confidence":"High","gaps":["Mechanism linking mRNA defects to ATP synthase subassembly not detailed","Tissue-specific severity not explained"]},{"year":2014,"claim":"Connected LRPPRC to Parkin-mediated mitophagy under stress, positioning it on the outer membrane interface during mitochondrial turnover.","evidence":"Co-IP, fractionation, and CCCP-induced mitophagy with Parkin/Bcl-2/LC3 westerns","pmids":["24722279"],"confidence":"Low","gaps":["Single Co-IP/pulldown without reciprocal structural validation","How a matrix protein becomes exposed on the OMM unexplained"]},{"year":2015,"claim":"Defined the SLIRP partnership: SLIRP stabilizes LRPPRC and is required for ribosome association and efficient translation but dispensable for polyadenylation, separating the complex's activities.","evidence":"Slirp knockout mice with ribosome-fraction RNA-seq and protein-stability and polyadenylation analyses","pmids":["26247782"],"confidence":"High","gaps":["Structural basis of the heterodimer not yet resolved at this stage","Why Slirp KO mice remain healthy despite mRNA loss unexplained"]},{"year":2016,"claim":"Provided the biochemical/structural basis of LRPPRC-SLIRP heterodimerization, showing SLIRP RRM RNP1 residues are repurposed for protein-protein contact while LRPPRC carries the broad RNA-binding capacity.","evidence":"In vitro RNA-binding assays, interface mutagenesis, and biochemical complex characterization","pmids":["27353330"],"confidence":"High","gaps":["Did not visualize the complex on RNA or the ribosome","Functional consequence of specific interface residues in vivo untested"]},{"year":2017,"claim":"Generalized LRPPRC-SLIRP function to a transcriptome-wide RNA chaperone that remodels mitochondrial mRNA secondary structure to expose functional sites, unifying its stabilization, polyadenylation, and translation roles.","evidence":"RNase footprinting combined with PAR-CLIP across the mitochondrial transcriptome","pmids":["29146908"],"confidence":"High","gaps":["Did not provide an atomic model of mRNA handoff","Transcript-specific translation effects not yet structurally explained"]},{"year":2024,"claim":"Delivered the structural endpoint: cryo-EM of LRPPRC-SLIRP on mRNA and the mitoribosome showing LRPPRC contacts mS39/mS31 to form an mRNA-handoff corridor, with COX1/COX2 most translation-dependent, and an in vivo study showed the complex is required for complex I maintenance with tissue-specific coordination.","evidence":"Cryo-EM with RNA-seq, metabolic labeling, ribosome profiling; plus knock-in/Slirp-KO mice and mtDNA double-mutant epistasis","pmids":["39134711","39087558"],"confidence":"High","gaps":["Dynamics of repeated mRNA loading/release not captured","Tissue specificity of coordination not mechanistically explained"]},{"year":2024,"claim":"Established a regulated turnover network for LRPPRC, with K453 K48-ubiquitination by STUB1 (controlled upstream by USP44) and stabilization by PSMD14, coupling LRPPRC levels to ROS, apoptosis, and chemosensitivity; SIRT3 deacetylation further tunes its activity.","evidence":"Co-IP, ubiquitination site mapping, deubiquitinase/deacetylase manipulation, and in vivo tumor models","pmids":["39215663","36328147","39557134"],"confidence":"Medium","gaps":["PSMD14 and SIRT3 studies lack mapped sites or are single-Co-IP","How matrix-localized LRPPRC accesses cytosolic ubiquitin machinery unresolved"]},{"year":2024,"claim":"Defined a cytoplasmic m6A-reader function for LRPPRC stabilizing oncogenic mRNAs—PD-L1, LDHA, CDK6, and MDR1—linking it to immune evasion, glycolysis, cell-cycle progression, and chemoresistance.","evidence":"MeRIP-seq/qPCR, RIP, RNA pull-down, mRNA stability and metabolic assays, with xenografts/organoids","pmids":["37063837","38372449","37452037","35484333"],"confidence":"Medium","gaps":["m6A-site mutagenesis to rigorously confirm reader function not done in several studies","How an annotated matrix protein achieves cytoplasmic mRNA binding not reconciled"]},{"year":null,"claim":"How LRPPRC partitions between its established mitochondrial matrix RNA-chaperone role and its reported nuclear/cytoplasmic transcriptional and m6A-reader functions remains the central unresolved question.","evidence":"No single study reconciles exclusive matrix localization with extramitochondrial activities","pmids":[],"confidence":"Low","gaps":["No mechanism for dual subcellular targeting","Whether extramitochondrial roles reflect a minor pool or distinct isoform unknown","Stoichiometry between PGC-1α coactivation and m6A reading undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[0,1,2,3,4,6,13,22,24,26,27]},{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[1,4]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[9,18,19,32]},{"term_id":"GO:0045182","term_label":"translation regulator activity","supporting_discovery_ids":[0,3,5]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[4]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[6,8]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[9,18,32]}],"pathway":[{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[0,1,3,4]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[9,11,19,27]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[9,18,32]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[15,30]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[12]}],"complexes":["LRPPRC-SLIRP complex","PGC-1α coactivator complex"],"partners":["SLIRP","PGC-1Α","MTPAP","BECLIN 1","BCL-2","STUB1","PSMD14","MAVS"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P42704","full_name":"Leucine-rich PPR motif-containing protein, mitochondrial","aliases":["130 kDa leucine-rich protein","LRP 130","GP130"],"length_aa":1394,"mass_kda":157.9,"function":"May play a role in RNA metabolism in both nuclei and mitochondria. In the nucleus binds to HNRPA1-associated poly(A) mRNAs and is part of nmRNP complexes at late stages of mRNA maturation which are possibly associated with nuclear mRNA export. Positively modulates nuclear export of mRNAs containing the EIF4E sensitivity element (4ESE) by binding simultaneously to both EIF4E and the 4ESE and acting as a platform for assembly for the RNA export complex (PubMed:19262567, PubMed:28325843). Also binds to exportin XPO1/CRM1 to engage the nuclear pore and traffic the bound mRNAs to the cytoplasm (PubMed:28325843). May bind mature mRNA in the nucleus outer membrane. In mitochondria binds to poly(A) mRNA. Plays a role in translation or stability of mitochondrially encoded cytochrome c oxidase (COX) subunits. May be involved in transcription regulation. Cooperates with PPARGC1A to regulate certain mitochondrially encoded genes and gluconeogenic genes and may regulate docking of PPARGC1A to transcription factors. Seems to be involved in the transcription regulation of the multidrug-related genes MDR1 and MVP. Part of a nuclear factor that binds to the invMED1 element of MDR1 and MVP gene promoters. Binds single-stranded DNA (By similarity). Required for maintaining mitochondrial potential (PubMed:23822101). Suppresses the initiation of basal levels of autophagy and mitophagy by sustaining BCL2 levels (PubMed:23822101)","subcellular_location":"Mitochondrion; Nucleus; Nucleus, nucleoplasm; Nucleus inner membrane; Nucleus outer membrane","url":"https://www.uniprot.org/uniprotkb/P42704/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/LRPPRC","classification":"Common Essential","n_dependent_lines":813,"n_total_lines":1208,"dependency_fraction":0.6730132450331126},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CALM1","stoichiometry":0.2},{"gene":"CALM2","stoichiometry":0.2},{"gene":"CALM3","stoichiometry":0.2},{"gene":"CAPZB","stoichiometry":0.2},{"gene":"HNRNPL","stoichiometry":0.2},{"gene":"IGF2BP1","stoichiometry":0.2},{"gene":"PABPC4","stoichiometry":0.2},{"gene":"PTGES3","stoichiometry":0.2},{"gene":"CCDC47","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/LRPPRC","total_profiled":1310},"omim":[{"mim_id":"621553","title":"GTP-BINDING PROTEIN 8; GTPBP8","url":"https://www.omim.org/entry/621553"},{"mim_id":"620808","title":"SMALL NUCLEOLAR RNA HOST GENE 17; SNHG17","url":"https://www.omim.org/entry/620808"},{"mim_id":"613669","title":"MITOCHONDRIAL POLY(A) POLYMERASE; MTPAP","url":"https://www.omim.org/entry/613669"},{"mim_id":"610211","title":"SRA STEM LOOP-INTERACTING RNA-BINDING PROTEIN; SLIRP","url":"https://www.omim.org/entry/610211"},{"mim_id":"608451","title":"ETHE1 PERSULFIDE DIOXYGENASE; ETHE1","url":"https://www.omim.org/entry/608451"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Mitochondria","reliability":"Enhanced"},{"location":"Acrosome","reliability":"Additional"},{"location":"Mid piece","reliability":"Additional"},{"location":"End piece","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/LRPPRC"},"hgnc":{"alias_symbol":["GP130","LRP130"],"prev_symbol":["LSFC"]},"alphafold":{"accession":"P42704","domains":[{"cath_id":"1.25.40,1.25.40","chopping":"660-745","consensus_level":"medium","plddt":82.9374,"start":660,"end":745},{"cath_id":"-","chopping":"1102-1175","consensus_level":"medium","plddt":83.5876,"start":1102,"end":1175},{"cath_id":"1.25.40","chopping":"2-9_77-174","consensus_level":"medium","plddt":72.2899,"start":2,"end":174},{"cath_id":"1.25.40","chopping":"537-650","consensus_level":"medium","plddt":79.332,"start":537,"end":650},{"cath_id":"1.25.40","chopping":"1036-1101","consensus_level":"medium","plddt":80.8938,"start":1036,"end":1101}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P42704","model_url":"https://alphafold.ebi.ac.uk/files/AF-P42704-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P42704-F1-predicted_aligned_error_v6.png","plddt_mean":77.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=LRPPRC","jax_strain_url":"https://www.jax.org/strain/search?query=LRPPRC"},"sequence":{"accession":"P42704","fasta_url":"https://rest.uniprot.org/uniprotkb/P42704.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P42704/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P42704"}},"corpus_meta":[{"pmid":"22045337","id":"PMC_22045337","title":"LRPPRC is necessary for polyadenylation and coordination of translation of mitochondrial mRNAs.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/22045337","citation_count":286,"is_preprint":false},{"pmid":"22661577","id":"PMC_22661577","title":"LRPPRC/SLIRP suppresses PNPase-mediated mRNA decay and promotes polyadenylation in human mitochondria.","date":"2012","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/22661577","citation_count":162,"is_preprint":false},{"pmid":"15139850","id":"PMC_15139850","title":"The role of the LRPPRC (leucine-rich pentatricopeptide repeat cassette) gene in cytochrome oxidase assembly: mutation causes lowered levels of COX (cytochrome c oxidase) I and COX III mRNA.","date":"2004","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15139850","citation_count":142,"is_preprint":false},{"pmid":"12832482","id":"PMC_12832482","title":"LRP130, a pentatricopeptide motif protein with a noncanonical RNA-binding domain, is bound in vivo to mitochondrial and nuclear RNAs.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12832482","citation_count":132,"is_preprint":false},{"pmid":"31178748","id":"PMC_31178748","title":"LRPPRC: A Multifunctional Protein Involved in Energy Metabolism and Human Disease.","date":"2019","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31178748","citation_count":105,"is_preprint":false},{"pmid":"29146908","id":"PMC_29146908","title":"LRPPRC-mediated folding of the mitochondrial transcriptome.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29146908","citation_count":103,"is_preprint":false},{"pmid":"24399447","id":"PMC_24399447","title":"Loss of LRPPRC causes ATP synthase deficiency.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24399447","citation_count":97,"is_preprint":false},{"pmid":"26510951","id":"PMC_26510951","title":"LRPPRC mutations cause early-onset multisystem mitochondrial disease outside of the French-Canadian population.","date":"2015","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/26510951","citation_count":87,"is_preprint":false},{"pmid":"17050673","id":"PMC_17050673","title":"Defects in energy homeostasis in Leigh syndrome French Canadian variant through PGC-1alpha/LRP130 complex.","date":"2006","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/17050673","citation_count":86,"is_preprint":false},{"pmid":"26247782","id":"PMC_26247782","title":"SLIRP Regulates the Rate of Mitochondrial Protein Synthesis and Protects LRPPRC from Degradation.","date":"2015","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26247782","citation_count":83,"is_preprint":false},{"pmid":"21266382","id":"PMC_21266382","title":"LRPPRC mutations cause a phenotypically distinct form of Leigh syndrome with cytochrome c oxidase deficiency.","date":"2011","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21266382","citation_count":79,"is_preprint":false},{"pmid":"20220140","id":"PMC_20220140","title":"Mitochondrial and nuclear genomic responses to loss of LRPPRC expression.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20220140","citation_count":74,"is_preprint":false},{"pmid":"35484333","id":"PMC_35484333","title":"Targeting the miR-34a/LRPPRC/MDR1 axis collapse the chemoresistance in P53 inactive colorectal cancer.","date":"2022","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/35484333","citation_count":72,"is_preprint":false},{"pmid":"11827465","id":"PMC_11827465","title":"Sequence analysis of LRPPRC and its SEC1 domain interaction partners suggests roles in cytoskeletal organization, vesicular trafficking, nucleocytosolic shuttling, and chromosome activity.","date":"2002","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/11827465","citation_count":68,"is_preprint":false},{"pmid":"23878239","id":"PMC_23878239","title":"Impaired complex IV activity in response to loss of LRPPRC function can be compensated by mitochondrial hyperfusion.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23878239","citation_count":68,"is_preprint":false},{"pmid":"23822101","id":"PMC_23822101","title":"Mitochondrion-associated protein LRPPRC suppresses the initiation of basal levels of autophagy via enhancing Bcl-2 stability.","date":"2013","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/23822101","citation_count":57,"is_preprint":false},{"pmid":"22326293","id":"PMC_22326293","title":"Role of leucine-rich pentatricopeptide repeat motif-containing protein (LRPPRC) for anti-apoptosis and tumourigenesis in cancers.","date":"2012","source":"European journal of cancer (Oxford, England : 1990)","url":"https://pubmed.ncbi.nlm.nih.gov/22326293","citation_count":54,"is_preprint":false},{"pmid":"21971050","id":"PMC_21971050","title":"LRP130 protein remodels mitochondria and stimulates fatty acid oxidation.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21971050","citation_count":50,"is_preprint":false},{"pmid":"25214534","id":"PMC_25214534","title":"Tissue-specific responses to the LRPPRC founder mutation in French Canadian Leigh Syndrome.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25214534","citation_count":50,"is_preprint":false},{"pmid":"18728005","id":"PMC_18728005","title":"Modulation of PGC-1 coactivator pathways in brown fat differentiation through LRP130.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18728005","citation_count":49,"is_preprint":false},{"pmid":"27353330","id":"PMC_27353330","title":"SLIRP stabilizes LRPPRC via an RRM-PPR protein interface.","date":"2016","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/27353330","citation_count":47,"is_preprint":false},{"pmid":"34671012","id":"PMC_34671012","title":"LncRNA SNHG17 interacts with LRPPRC to stabilize c-Myc protein and promote G1/S transition and cell proliferation.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34671012","citation_count":45,"is_preprint":false},{"pmid":"20633537","id":"PMC_20633537","title":"LRPPRC is a mitochondrial matrix protein that is conserved in metazoans.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20633537","citation_count":45,"is_preprint":false},{"pmid":"24722279","id":"PMC_24722279","title":"Autophagy inhibitor LRPPRC suppresses mitophagy through interaction with mitophagy initiator Parkin.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24722279","citation_count":43,"is_preprint":false},{"pmid":"28575497","id":"PMC_28575497","title":"Loss of hepatic LRPPRC alters mitochondrial bioenergetics, regulation of permeability transition and trans-membrane ROS diffusion.","date":"2017","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28575497","citation_count":43,"is_preprint":false},{"pmid":"37063837","id":"PMC_37063837","title":"LRPPRC facilitates tumor progression and immune evasion through upregulation of m6A modification of PD-L1 mRNA in hepatocellular carcinoma.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37063837","citation_count":42,"is_preprint":false},{"pmid":"24375316","id":"PMC_24375316","title":"The significance of LRPPRC overexpression in gastric cancer.","date":"2013","source":"Medical oncology (Northwood, London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/24375316","citation_count":40,"is_preprint":false},{"pmid":"32203162","id":"PMC_32203162","title":"LRPPRC sustains Yap-P27-mediated cell ploidy and P62-HDAC6-mediated autophagy maturation and suppresses genome instability and hepatocellular carcinomas.","date":"2020","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/32203162","citation_count":38,"is_preprint":false},{"pmid":"30070380","id":"PMC_30070380","title":"Negative Regulation of Mitochondrial Antiviral Signaling Protein-Mediated Antiviral Signaling by the Mitochondrial Protein LRPPRC During Hepatitis C Virus Infection.","date":"2018","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/30070380","citation_count":38,"is_preprint":false},{"pmid":"34864630","id":"PMC_34864630","title":"LRPPRC regulates redox homeostasis via the circANKHD1/FOXM1 axis to enhance bladder urothelial carcinoma tumorigenesis.","date":"2021","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/34864630","citation_count":38,"is_preprint":false},{"pmid":"15081402","id":"PMC_15081402","title":"LRP130, a single-stranded DNA/RNA-binding protein, localizes at the outer nuclear and endoplasmic reticulum membrane, and interacts with mRNA in vivo.","date":"2004","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15081402","citation_count":37,"is_preprint":false},{"pmid":"12071956","id":"PMC_12071956","title":"LRP130, a protein containing nine pentatricopeptide repeat motifs, interacts with a single-stranded cytosine-rich sequence of mouse hypervariable minisatellite Pc-1.","date":"2002","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12071956","citation_count":37,"is_preprint":false},{"pmid":"37452037","id":"PMC_37452037","title":"The RNA-binding protein LRPPRC promotes resistance to CDK4/6 inhibition in lung cancer.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37452037","citation_count":35,"is_preprint":false},{"pmid":"39134711","id":"PMC_39134711","title":"Structural basis of LRPPRC-SLIRP-dependent translation by the mitoribosome.","date":"2024","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/39134711","citation_count":34,"is_preprint":false},{"pmid":"32497722","id":"PMC_32497722","title":"Alzheimer's and Parkinson's brain tissues have reduced expression of genes for mtDNA OXPHOS Proteins, mitobiogenesis regulator PGC-1α protein and mtRNA stabilizing protein LRPPRC (LRP130).","date":"2020","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/32497722","citation_count":34,"is_preprint":false},{"pmid":"21880015","id":"PMC_21880015","title":"LRPPRC mutation suppresses cytochrome oxidase activity by altering mitochondrial RNA transcript stability in a mouse model.","date":"2012","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/21880015","citation_count":34,"is_preprint":false},{"pmid":"27604398","id":"PMC_27604398","title":"The effect of acute and chronic sprint-interval training on LRP130, SIRT3, and PGC-1α expression in human skeletal muscle.","date":"2016","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/27604398","citation_count":33,"is_preprint":false},{"pmid":"34589577","id":"PMC_34589577","title":"LRPPRC regulates metastasis and glycolysis by modulating autophagy and the ROS/HIF1-α pathway in retinoblastoma.","date":"2021","source":"Molecular therapy oncolytics","url":"https://pubmed.ncbi.nlm.nih.gov/34589577","citation_count":30,"is_preprint":false},{"pmid":"32972427","id":"PMC_32972427","title":"Novel LRPPRC compound heterozygous mutation in a child with early-onset Leigh syndrome French-Canadian type: case report of an Italian patient.","date":"2020","source":"Italian journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/32972427","citation_count":29,"is_preprint":false},{"pmid":"15272088","id":"PMC_15272088","title":"New invMED1 element cis-activates human multidrug-related MDR1 and MVP genes, involving the LRP130 protein.","date":"2004","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/15272088","citation_count":28,"is_preprint":false},{"pmid":"23599432","id":"PMC_23599432","title":"The leucine-rich pentatricopeptide repeat-containing protein (LRPPRC) does not activate transcription in mammalian mitochondria.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23599432","citation_count":27,"is_preprint":false},{"pmid":"27462273","id":"PMC_27462273","title":"Increased Hepatic Fatty Acids Uptake and Oxidation by LRPPRC-Driven Oxidative Phosphorylation Reduces Blood Lipid Levels.","date":"2016","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/27462273","citation_count":27,"is_preprint":false},{"pmid":"26412102","id":"PMC_26412102","title":"The loss of LRPPRC function induces the mitochondrial unfolded protein response.","date":"2015","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/26412102","citation_count":25,"is_preprint":false},{"pmid":"36328147","id":"PMC_36328147","title":"Deubiquitylase PSMD14 inhibits autophagy to promote ovarian cancer progression via stabilization of LRPPRC.","date":"2022","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/36328147","citation_count":24,"is_preprint":false},{"pmid":"37496051","id":"PMC_37496051","title":"A traditional gynecological medicine inhibits ovarian cancer progression and eliminates cancer stem cells via the LRPPRC-OXPHOS axis.","date":"2023","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37496051","citation_count":24,"is_preprint":false},{"pmid":"38372449","id":"PMC_38372449","title":"LRPPRC promotes glycolysis by stabilising LDHA mRNA and its knockdown plus glutamine inhibitor induces synthetic lethality via m6 A modification in triple-negative breast cancer.","date":"2024","source":"Clinical and translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38372449","citation_count":23,"is_preprint":false},{"pmid":"25631043","id":"PMC_25631043","title":"The viral restriction factor tetherin prevents leucine-rich pentatricopeptide repeat-containing protein (LRPPRC) from association with beclin 1 and B-cell CLL/lymphoma 2 (Bcl-2) and enhances autophagy and mitophagy.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25631043","citation_count":23,"is_preprint":false},{"pmid":"36300799","id":"PMC_36300799","title":"A/(H1N1) pdm09 NS1 promotes viral replication by enhancing autophagy through hijacking the IAV negative regulatory factor LRPPRC.","date":"2022","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/36300799","citation_count":21,"is_preprint":false},{"pmid":"39557134","id":"PMC_39557134","title":"SIRT3 alleviates mitochondrial dysfunction and senescence in diabetes-associated periodontitis by deacetylating LRPPRC.","date":"2024","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39557134","citation_count":21,"is_preprint":false},{"pmid":"32149459","id":"PMC_32149459","title":"LncRNA GUARDIN suppresses cellular senescence through a LRP130-PGC1α-FOXO4-p21-dependent signaling axis.","date":"2020","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/32149459","citation_count":20,"is_preprint":false},{"pmid":"22808186","id":"PMC_22808186","title":"Knockdown of the cellular protein LRPPRC attenuates HIV-1 infection.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22808186","citation_count":20,"is_preprint":false},{"pmid":"22458888","id":"PMC_22458888","title":"A comparative proteomic study identified LRPPRC and MCM7 as putative actors in imatinib mesylate cross-resistance in Lucena cell line.","date":"2012","source":"Proteome science","url":"https://pubmed.ncbi.nlm.nih.gov/22458888","citation_count":19,"is_preprint":false},{"pmid":"39087558","id":"PMC_39087558","title":"LRPPRC and SLIRP synergize to maintain sufficient and orderly mammalian mitochondrial translation.","date":"2024","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/39087558","citation_count":18,"is_preprint":false},{"pmid":"28622966","id":"PMC_28622966","title":"Immunohistochemical expression analysis of leucine-rich PPR-motif-containing protein (LRPPRC), a candidate colorectal cancer biomarker identified by shotgun proteomics using iTRAQ.","date":"2017","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28622966","citation_count":17,"is_preprint":false},{"pmid":"25991827","id":"PMC_25991827","title":"Aerobic Exercise Recovers Disuse-induced Atrophy Through the Stimulus of the LRP130/PGC-1α Complex in Aged Rats.","date":"2015","source":"The journals of gerontology. Series A, Biological sciences and medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/25991827","citation_count":16,"is_preprint":false},{"pmid":"25089713","id":"PMC_25089713","title":"ABCB1 regulation through LRPPRC is influenced by the methylation status of the GC -100 box in its promoter.","date":"2014","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/25089713","citation_count":16,"is_preprint":false},{"pmid":"33649818","id":"PMC_33649818","title":"LRPPRC contributes to the cisplatin resistance of lung cancer cells by regulating MDR1 expression.","date":"2021","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/33649818","citation_count":15,"is_preprint":false},{"pmid":"40133967","id":"PMC_40133967","title":"LRPPRC confers enhanced oxidative phosphorylation metabolism in triple-negative breast cancer and represents a therapeutic target.","date":"2025","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/40133967","citation_count":14,"is_preprint":false},{"pmid":"29152527","id":"PMC_29152527","title":"Novel LRPPRC Mutation in a Boy With Mild Leigh Syndrome, French-Canadian Type Outside of Québec.","date":"2017","source":"Child neurology open","url":"https://pubmed.ncbi.nlm.nih.gov/29152527","citation_count":14,"is_preprint":false},{"pmid":"30995105","id":"PMC_30995105","title":"mTORC1 is required for expression of LRPPRC and cytochrome-c oxidase but not HIF-1α in Leigh syndrome French Canadian type patient fibroblasts.","date":"2019","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30995105","citation_count":13,"is_preprint":false},{"pmid":"38697422","id":"PMC_38697422","title":"Targeting leucine-rich PPR motif-containing protein/LRPPRC by 5,7,4'-trimethoxyflavone suppresses esophageal squamous cell carcinoma progression.","date":"2024","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/38697422","citation_count":13,"is_preprint":false},{"pmid":"33312877","id":"PMC_33312877","title":"Poly (A) tail length of human mitochondrial mRNAs is tissue-specific and a mutation in LRPPRC results in transcript-specific patterns of deadenylation.","date":"2020","source":"Molecular genetics and metabolism reports","url":"https://pubmed.ncbi.nlm.nih.gov/33312877","citation_count":13,"is_preprint":false},{"pmid":"37789316","id":"PMC_37789316","title":"LRPPRC regulates malignant behaviors, protects mitochondrial homeostasis, mitochondrial function in osteosarcoma and derived cancer stem-like cells.","date":"2023","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/37789316","citation_count":11,"is_preprint":false},{"pmid":"25379610","id":"PMC_25379610","title":"Downregulation of LRPPRC induces apoptosis in prostate cancer cells through the mitochondria-mediated pathway.","date":"2014","source":"Cancer biotherapy & radiopharmaceuticals","url":"https://pubmed.ncbi.nlm.nih.gov/25379610","citation_count":11,"is_preprint":false},{"pmid":"39476900","id":"PMC_39476900","title":"Comprehensive review on leucine-rich pentatricopeptide repeat-containing protein (LRPPRC, PPR protein): A burgeoning target for cancer therapy.","date":"2024","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/39476900","citation_count":10,"is_preprint":false},{"pmid":"32898195","id":"PMC_32898195","title":"Propofol induces mitochondrial-associated protein LRPPRC and protects mitochondria against hypoxia in cardiac cells.","date":"2020","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/32898195","citation_count":10,"is_preprint":false},{"pmid":"39215663","id":"PMC_39215663","title":"The deubiquitinase USP44 enhances cisplatin chemosensitivity through stabilizing STUB1 to promote LRPPRC degradation in neuroblastoma.","date":"2025","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/39215663","citation_count":10,"is_preprint":false},{"pmid":"39744573","id":"PMC_39744573","title":"Demethylzeylasteral inhibits oxidative phosphorylation complex biogenesis by targeting LRPPRC in lung cancer.","date":"2025","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/39744573","citation_count":10,"is_preprint":false},{"pmid":"35792704","id":"PMC_35792704","title":"LRPPRC inhibits autophagy and promotes foam cell formation in atherosclerosis.","date":"2022","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/35792704","citation_count":9,"is_preprint":false},{"pmid":"34413467","id":"PMC_34413467","title":"Adaptive optimization of the OXPHOS assembly line partially compensates lrpprc-dependent mitochondrial translation defects in mice.","date":"2021","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/34413467","citation_count":9,"is_preprint":false},{"pmid":"38643468","id":"PMC_38643468","title":"An LRPPRC-HAPSTR1-PSMD14 interaction regulates tumor progression in ovarian cancer.","date":"2024","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/38643468","citation_count":7,"is_preprint":false},{"pmid":"39164777","id":"PMC_39164777","title":"hsa_circ_0020093 suppresses ovarian cancer progression by modulating LRPPRC activity and miR-107/LATS2 signaling.","date":"2024","source":"Biology direct","url":"https://pubmed.ncbi.nlm.nih.gov/39164777","citation_count":7,"is_preprint":false},{"pmid":"38690512","id":"PMC_38690512","title":"Gossypol acetic acid regulates leukemia stem cells by degrading LRPPRC via inhibiting IL-6/JAK1/STAT3 signaling or resulting mitochondrial dysfunction.","date":"2024","source":"World journal of stem cells","url":"https://pubmed.ncbi.nlm.nih.gov/38690512","citation_count":7,"is_preprint":false},{"pmid":"32065259","id":"PMC_32065259","title":"Fiber-specific and whole-muscle LRP130 expression in rested, exercised, and fasted human skeletal muscle.","date":"2020","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32065259","citation_count":6,"is_preprint":false},{"pmid":"39612279","id":"PMC_39612279","title":"N6-Methyladenosine (m6A) Reader LRPPRC-Mediated CXCL11 Induces Cell Inflammation to Drive Breast Cancer Cell Malignancy.","date":"2025","source":"Critical reviews in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/39612279","citation_count":6,"is_preprint":false},{"pmid":"34986434","id":"PMC_34986434","title":"Pseudorabies virus UL16 protein influences the inhibition of LRPPRC for the viral proliferation.","date":"2021","source":"Veterinary microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/34986434","citation_count":6,"is_preprint":false},{"pmid":"32855734","id":"PMC_32855734","title":"Mitochondria-associated protein LRPPRC exerts cardioprotective effects against doxorubicin-induced toxicity, potentially via inhibition of ROS accumulation.","date":"2020","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32855734","citation_count":6,"is_preprint":false},{"pmid":"39395319","id":"PMC_39395319","title":"Design, synthesis, and biological evaluation of novel 5,7,4'-trimethoxyflavone sulfonamide-based derivatives as highly potent inhibitors of LRPPRC/STAT3/CDK1.","date":"2024","source":"Bioorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39395319","citation_count":5,"is_preprint":false},{"pmid":"39631618","id":"PMC_39631618","title":"METTL3-mediated SMPDL3A promotes cell growth, metastasis and immune process of hepatocellular carcinoma by regulating LRPPRC.","date":"2024","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/39631618","citation_count":5,"is_preprint":false},{"pmid":"37098042","id":"PMC_37098042","title":"Bendless is essential for PINK1-Park mediated Mitofusin degradation under mitochondrial stress caused by loss of LRPPRC.","date":"2023","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37098042","citation_count":5,"is_preprint":false},{"pmid":"38046674","id":"PMC_38046674","title":"A novel homozygous splice donor variant in the LRPPRC gene causing Leigh syndrome with epilepsy, a French-Canadian disorder in a Saudi family: case report.","date":"2023","source":"Frontiers in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/38046674","citation_count":3,"is_preprint":false},{"pmid":"40611540","id":"PMC_40611540","title":"Identification and validation of the m6A-binding protein LRPPRC to promote tumorigenesis in multiple myeloma.","date":"2025","source":"Hematology (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/40611540","citation_count":2,"is_preprint":false},{"pmid":"40957301","id":"PMC_40957301","title":"LRPPRC promotes the progression of colorectal cancer via HIF-1ꭤ/VEGF-meditated angiogenesis.","date":"2025","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/40957301","citation_count":2,"is_preprint":false},{"pmid":"40587247","id":"PMC_40587247","title":"The Biological Role of LRPPRC in Human Cancers.","date":"2025","source":"Cancer control : journal of the Moffitt Cancer Center","url":"https://pubmed.ncbi.nlm.nih.gov/40587247","citation_count":2,"is_preprint":false},{"pmid":"38706791","id":"PMC_38706791","title":"Human induced pluripotent stem cells (hiPSCs) derived cells reflect tissue specificity found in patients with Leigh syndrome French Canadian variant (LSFC).","date":"2024","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38706791","citation_count":2,"is_preprint":false},{"pmid":"40775462","id":"PMC_40775462","title":"Leucyl-tRNA synthetase promotes malignant progression in diffuse large B-cell lymphoma by regulating glycolysis via the LRPPRC/HIF-1α/HK2 axis.","date":"2025","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/40775462","citation_count":2,"is_preprint":false},{"pmid":"40255566","id":"PMC_40255566","title":"Landscape analysis of m6A modification regulators reveals LRPPRC as a key modulator in tubule cells for DKD: a multi-omics study.","date":"2025","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/40255566","citation_count":2,"is_preprint":false},{"pmid":"41491301","id":"PMC_41491301","title":"Therapeutic targeting LRPPRC-mediated OXPHOS synthesis for cancer intervention.","date":"2026","source":"Expert opinion on therapeutic targets","url":"https://pubmed.ncbi.nlm.nih.gov/41491301","citation_count":1,"is_preprint":false},{"pmid":"41516324","id":"PMC_41516324","title":"LRPPRC-Driven Oxidative Phosphorylation Is Associated with Elesclomol-Induced Cuproptosis in Ovarian Cancer.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41516324","citation_count":1,"is_preprint":false},{"pmid":"40563592","id":"PMC_40563592","title":"The Identification of a Key Regulator of Mitochondrial Metabolism, the LRPPRC Protein, as a Novel Therapeutic Target in SDHA-Overexpressing Ovarian Tumors.","date":"2025","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/40563592","citation_count":1,"is_preprint":false},{"pmid":"31223111","id":"PMC_31223111","title":"[Knock-down of leucine-rich pentatricopeptide repeat containing(LRPPRC) promotes apoptosis of hormone resistant prostate cancer cells].","date":"2019","source":"Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31223111","citation_count":1,"is_preprint":false},{"pmid":"40607235","id":"PMC_40607235","title":"Disruption of Lrpprc affects B cell development and proliferation in a mouse model of Leigh Syndrome French Canadian type.","date":"2025","source":"Journal of rare diseases (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/40607235","citation_count":0,"is_preprint":false},{"pmid":"40555877","id":"PMC_40555877","title":"Leucine-rich pentatricopeptide repeat-containing protein (LRPPRC)-stabilized lncRNA small nucleolar RNA host gene 15 (Snhg15) modulates hematopoietic injury induced by γ-ray irradiation via m6A modification.","date":"2025","source":"Molecular biomedicine","url":"https://pubmed.ncbi.nlm.nih.gov/40555877","citation_count":0,"is_preprint":false},{"pmid":"41612594","id":"PMC_41612594","title":"PRKAB2 as a tumor suppressor in renal cell carcinoma: inhibiting mitophagy via the LRPPRC-PRKN/parkin interaction and cardiolipin biosynthesis.","date":"2026","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/41612594","citation_count":0,"is_preprint":false},{"pmid":"41274398","id":"PMC_41274398","title":"Mitochondria-located circRCP regulates redox homeostasis via stabilizing LRPPRC/SLIRP complex to promote bladder urothelial carcinoma tumorigenesis.","date":"2025","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/41274398","citation_count":0,"is_preprint":false},{"pmid":"41969495","id":"PMC_41969495","title":"Targeting LRPPRC lactylation disrupts metabolic-immune crosstalk and restores antitumor immunity in hepatocellular carcinoma.","date":"2026","source":"Translational cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/41969495","citation_count":0,"is_preprint":false},{"pmid":"41901318","id":"PMC_41901318","title":"Synergistic Anti-Tumor Activity of LRPPRC Inhibition and Dasatinib Through Dual Oxidative Phosphorylation Disruption.","date":"2026","source":"Pharmaceuticals (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/41901318","citation_count":0,"is_preprint":false},{"pmid":"41529605","id":"PMC_41529605","title":"Design, synthesis, and antitumor activity of novel Flavokawain A derivatives by suppressing LRPPRC-YBX1-RPN1 cascade.","date":"2026","source":"Bioorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/41529605","citation_count":0,"is_preprint":false},{"pmid":"40223205","id":"PMC_40223205","title":"Programmable Loading of a Multivalent LRPPRC Aptamer onto a Rectangular DNA Tile Inhibits the Proliferation of Lung Adenocarcinoma Cells.","date":"2025","source":"ACS applied materials & interfaces","url":"https://pubmed.ncbi.nlm.nih.gov/40223205","citation_count":0,"is_preprint":false},{"pmid":"42232680","id":"PMC_42232680","title":"Two Siblings with LRPPRC Mutation: Mitochondrial Complex IV Deficiency: Case Report.","date":"2025","source":"Molecular syndromology","url":"https://pubmed.ncbi.nlm.nih.gov/42232680","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54547,"output_tokens":8488,"usd":0.145481,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18457,"output_tokens":6563,"usd":0.12818,"stage2_stop_reason":"end_turn"},"total_usd":0.273661,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2024,\n      \"finding\": \"Cryo-EM structure of LRPPRC-SLIRP complex bound to mRNA and the mitoribosome shows that LRPPRC associates with mitoribosomal proteins mS39 and the N-terminus of mS31 through its helical (PPR) repeats, forming a corridor for mRNA handoff to the ribosome; SLIRP directly binds the mRNA and stabilizes LRPPRC within the complex. RNA sequencing, metabolic labeling, and ribosome profiling show transcript-specific effects on translation efficiency, with COX1 and COX2 translation most affected.\",\n      \"method\": \"Cryo-electron microscopy structure determination, RNA sequencing, metabolic labeling, mitoribosome profiling\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cryo-EM structure with multiple orthogonal functional validation methods (metabolic labeling, ribosome profiling, RNA-seq) in a single rigorous study\",\n      \"pmids\": [\"39134711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"LRPPRC in complex with SLIRP acts as a global RNA chaperone throughout the mitochondrial transcriptome, stabilizing RNA secondary structures to expose sites required for translation, stabilization, and polyadenylation. RNase footprinting combined with PAR-CLIP showed LRPPRC-SLIRP binds preferentially to mRNAs, and its loss alters the entire secondary structure and stability of the mitochondrial transcriptome.\",\n      \"method\": \"RNase footprinting, PAR-CLIP (photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation)\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — two orthogonal high-throughput RNA-protein mapping methods (PAR-CLIP + RNase footprinting) at unprecedented depth in a single study\",\n      \"pmids\": [\"29146908\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"LRPPRC-SLIRP form a heterodimer via interactions between polar amino acids in the single RRM domain of SLIRP and three neighboring PPR motifs in the second quarter of LRPPRC. Specific residues at this interface, predicted to bind RNA in LRPPRC and located in the RNP1 motif of SLIRP's RRM, are instead used for protein-protein interaction, enabling stable complex formation. In vitro binding assays showed LRPPRC has broad RNA-binding capacity while SLIRP associates only weakly with RNA.\",\n      \"method\": \"In vitro RNA-binding assays, mutagenesis of interaction interface, biochemical characterization of LRPPRC-SLIRP complex\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro reconstitution with mutagenesis, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"27353330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Tissue-specific knockout of Lrpprc in mouse heart causes drastic reduction in steady-state levels of most mitochondrial mRNAs, loss of mRNA polyadenylation, and aberrant mitochondrial translation with excessive translation of some transcripts and absent translation of others. LRPPRC forms an RNA-dependent protein complex necessary for maintaining a pool of non-translated mRNAs.\",\n      \"method\": \"Conditional knockout mouse model, Northern blot, mitochondrial translation assay, protein complex analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean conditional KO with multiple defined molecular phenotypes (mRNA stability, polyadenylation, translation), replicated across tissues\",\n      \"pmids\": [\"22045337\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The LRPPRC/SLIRP complex suppresses 3' exonucleolytic mRNA degradation mediated by PNPase and SUV3 and cotranscriptionally binds coding sequences of mitochondrial mRNAs. In vitro, LRPPRC promoted polyadenylation of mRNAs mediated by mitochondrial poly(A) polymerase (MTPAP).\",\n      \"method\": \"In vitro polyadenylation assay with MTPAP, RNA degradation assay with PNPase/SUV3, RNA immunoprecipitation, absolute quantification of mitochondrial mRNAs\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro reconstitution of polyadenylation and degradation suppression activities, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"22661577\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"SLIRP stabilizes LRPPRC by protecting it from degradation; LRPPRC is partially degraded when the LRPPRC-SLIRP complex is disrupted. SLIRP is required for proper association of mRNAs with the mitochondrial ribosome and efficient translation, but is dispensable for mRNA polyadenylation. Slirp knockout mice show 50–70% reduction in mtDNA-encoded mRNAs despite being apparently healthy.\",\n      \"method\": \"Slirp knockout mice, deep RNA sequencing of mitochondrial ribosomal fractions, molecular analyses of polyadenylation and translation\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo KO model with multiple orthogonal molecular readouts (ribosome-associated RNA-seq, polyadenylation analysis, protein stability assays)\",\n      \"pmids\": [\"26247782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"LRP130/LRPPRC is directly bound in vivo to mitochondrial polyadenylated RNAs and to nuclear mRNAs also associated with hnRNP A1. In vitro, LRP130 binds preferentially to polypyrimidines, with RNA-binding activity mapping to a C-terminal domain containing only 2 of 11 predicted PPR motifs — a novel non-canonical RNA-binding domain. The majority of LRP130 is localized within mitochondria.\",\n      \"method\": \"In vivo RNA crosslinking/immunoprecipitation, in vitro RNA-binding assays, subcellular fractionation, domain mapping\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo crosslinking combined with in vitro domain mapping, first identification of mitochondrial RNA binding, multiple orthogonal methods\",\n      \"pmids\": [\"12832482\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"LRPPRC does not activate mitochondrial transcription. Size exclusion chromatography and immunoprecipitation in human cell lines and mice found no interaction between LRPPRC and the mitochondrial RNA polymerase POLRMT. Addition of purified LRPPRC to a recombinant in vitro transcription system did not activate mtDNA transcription. Variation of LRPPRC levels in vivo affected unprocessed precursor transcript levels but not steady-state mRNA levels or de novo transcription.\",\n      \"method\": \"Size exclusion chromatography, co-immunoprecipitation, in vitro transcription reconstitution, BAC transgenic mice, heterozygous knockout mice\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro reconstitution showing no transcriptional activation, negative co-IP replicated in multiple systems, in vivo transgenic models; this is a rigorously established negative result\",\n      \"pmids\": [\"23599432\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"LRPPRC is exclusively localized to the mitochondrial matrix in mammalian cells; a single protein isoform exists, its mitochondrial targeting sequence is cleaved upon import, and orthologs are restricted to metazoans with conserved mitochondrial targeting signals.\",\n      \"method\": \"Subcellular fractionation, bioinformatic analysis of targeting sequences, direct protein localization experiments in mammalian cells\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct fractionation experiments plus bioinformatics, single lab, two complementary methods\",\n      \"pmids\": [\"20633537\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"LRP130/LRPPRC is a component of the PGC-1α transcriptional coactivator complex and is required for PGC-1α-dependent expression of gluconeogenic genes PEPCK and G6P, as well as certain mitochondrial genes. Adenoviral RNAi knockdown of LRP130 in fasted mice blocked PEPCK and G6P induction and blunted hepatic glucose output.\",\n      \"method\": \"Co-purification/mass spectrometry identification of PGC-1α complex components, adenoviral RNAi in mice, gene expression analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo RNAi with defined metabolic phenotype plus biochemical identification of complex, multiple orthogonal methods\",\n      \"pmids\": [\"17050673\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"LRP130/LRPPRC complexes with the mitochondrial RNA polymerase (POLRMT) to activate mitochondrial transcription (as assessed by convergent genetic and biochemical approaches), which is associated with increased OXPHOS activity, increased supercomplex formation, denser cristae, and increased hepatic β-fatty acid oxidation.\",\n      \"method\": \"Co-immunoprecipitation, genetic overexpression, biochemical OXPHOS activity assays, fatty acid oxidation assay with 14C-palmitate\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP claim for POLRMT interaction contradicted by a more rigorous study (PMID:23599432) using in vitro reconstitution and multiple Co-IP approaches that found no interaction; confidence accordingly low\",\n      \"pmids\": [\"21971050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Loss of LRPPRC in conditional knockout mouse hearts causes ATP synthase deficiency rather than solely COX deficiency; inactive subassembled ATP synthase complexes accumulate, causing mitochondrial hyperpolarization and increased reactive oxygen species production.\",\n      \"method\": \"Conditional Lrpprc knockout mouse hearts, OXPHOS complex activity assays, mitochondrial membrane potential measurement, ROS measurement\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean conditional KO with multiple defined biochemical phenotypes, in vivo mouse model\",\n      \"pmids\": [\"24399447\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"LRPPRC protein levels are reduced to <30% of control in fibroblast and liver mitochondria from LSFC patients carrying the A354V mutation. Reduced LRPPRC results in decreased COX I and COX III mRNA levels and specifically reduced translation of COX I. Import of the mutant A354V LRPPRC into rat liver mitochondria is slower than wild-type.\",\n      \"method\": \"Northern blot for mitochondrial mRNAs, [35S]methionine mitochondrial translation labeling, mitochondrial import assay, immunofluorescence\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (mRNA, translation, import assays) in patient cells, single lab\",\n      \"pmids\": [\"15139850\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"LRPPRC requires its first 19 PPR motifs for full binding to COX I mRNA; a specific segment of COX I mRNA encoded by mouse mtDNA nucleotides 5961–6020 was identified as the binding target. Homozygous LRPPRC C-terminus truncation causes embryonic lethality and major decrease in COX activity in mouse embryonic fibroblasts.\",\n      \"method\": \"Recombinant protein expression with PPR domain truncations, in vitro RNA-binding assay, gene-trap mouse model, COX activity assay\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro domain mapping with recombinant proteins plus in vivo knockout, single lab\",\n      \"pmids\": [\"21880015\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Reducing mma-1/LRPPRC function in C. elegans and mammalian cells causes mitochondrial hyperfusion as a compensatory response to decreased complex IV activity. Preventing mitochondrial hyperfusion in mma-1 animals causes larval arrest and embryonic lethality. Prolonged LRPPRC knockdown in mammalian cells leads to subsequent mitochondrial fragmentation and decreased ATP.\",\n      \"method\": \"C. elegans mma-1 mutants and mammalian LRPPRC knockdown, live-cell mitochondrial morphology imaging, genetic epistasis, ATP measurement\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — epistasis experiments in two organisms (C. elegans and mammalian cells), live imaging, defined physiological phenotype\",\n      \"pmids\": [\"23878239\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"LRPPRC interacts with Beclin 1 and Bcl-2 to form a ternary complex that maintains Bcl-2 stability. Suppression of LRPPRC reduces mitochondrial membrane potential and Bcl-2 levels, releasing Beclin 1 to activate the PI3K/Akt/mTOR autophagy pathway, thereby initiating basal autophagy and mitochondrial turnover.\",\n      \"method\": \"Co-immunoprecipitation, GFP-LC3 puncta assay, LC3-II/p62 western blot, siRNA knockdown in multiple cell lines, mitochondrial membrane potential assay\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — reciprocal Co-IP with functional KD phenotype, single lab, multiple cell lines and markers\",\n      \"pmids\": [\"23822101\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Under mitophagy stress, Parkin translocates to mitochondria and binds to exposed LRPPRC on the outer mitochondrial membrane. LRPPRC maintains Parkin stability (Parkin mono-ubiquitinates Bcl-2 to increase its stability and inhibit autophagy). LRPPRC and Parkin together facilitate engulfment of mitochondria into autophagosomes.\",\n      \"method\": \"Co-immunoprecipitation, subcellular fractionation, CCCP-induced mitophagy, western blot for Parkin/Bcl-2/LC3 markers\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP/pulldown approach, single lab, interaction under stress conditions only partially validated\",\n      \"pmids\": [\"24722279\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"LRPPRC knockdown in mammalian cells causes an imbalance between mitochondria-encoded and nuclear-encoded complex IV subunits that triggers the mitochondrial unfolded protein response (UPRmt). Inactivation of LRPPRC homolog mma-1 in C. elegans also induces UPRmt, demonstrating evolutionary conservation. Mitochondrial hyperfusion and UPRmt are coordinated but mediated by genetically distinct pathways.\",\n      \"method\": \"siRNA knockdown in mammalian cells, C. elegans mma-1 mutants, UPRmt reporter assays, genetic epistasis\",\n      \"journal\": \"Aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in two organisms, UPRmt reporter assay, single lab\",\n      \"pmids\": [\"26412102\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"LRP130/LRPPRC binds to a 12 bp invMED1 cis-activating element in the MDR1 gene promoter as a nuclear factor, and its binding intensity correlates with MDR1 expression level. LRP130 regulates transcriptional activity of both MDR1 and MVP gene promoters, as demonstrated by siRNA and transcriptional decoys.\",\n      \"method\": \"Electrophoretic mobility shift assay, siRNA knockdown, transcriptional decoys, luciferase reporter assay, chromatin immunoprecipitation\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus functional reporter assay and siRNA in multiple cell lines, single lab\",\n      \"pmids\": [\"15272088\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"LRP130 is a binding partner of PGC-1α in brown adipocytes, is preferentially enriched in brown fat, and is required for PGC-1α-dependent expression of UCP1 and other brown fat genes. Brown fat cells deficient for LRP130 exhibit reduced proton leak due to attenuated UCP1 expression.\",\n      \"method\": \"Co-immunoprecipitation, LRP130 knockdown in brown adipocytes, oxygen consumption assay, gene expression analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with functional KD, oxygen consumption readout, single lab\",\n      \"pmids\": [\"18728005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"LRPPRC acts as a negative regulator of MAVS-mediated antiviral signaling by interacting with MAVS and inhibiting its association with TRAF3 and TRAF6. LRPPRC knockdown results in inhibition of HCV infection associated with increased IFN response activation. The HCV NS5A protein exploits LRPPRC to interfere with MAVS activity in a LRPPRC-dependent manner.\",\n      \"method\": \"Co-immunoprecipitation (LRPPRC-MAVS, MAVS-TRAF3, MAVS-TRAF6), siRNA knockdown, HCV infection assay, IFN response measurement\",\n      \"journal\": \"Hepatology (Baltimore, Md.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — reciprocal Co-IP in multiple combinations, functional knockdown phenotype, single lab\",\n      \"pmids\": [\"30070380\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SIRT3 binds to and deacetylates LRPPRC, and this deacetylation modulates mitochondrial function (oxidative phosphorylation and oxidative stress) and cellular senescence. LRPPRC in turn regulates senescence by modulating OXPHOS and oxidative stress.\",\n      \"method\": \"Co-immunoprecipitation, western blot with acetylation antibodies, SIRT3 overexpression/knockdown, in vitro and in vivo senescence assays\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP plus phenotypic assays, single lab, no deacetylation site mapped by mutagenesis in the abstract\",\n      \"pmids\": [\"39557134\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"LRPPRC specifically binds to MDR1 mRNA and increases its stability and protein expression. P53-induced miR-34a suppresses LRPPRC expression; when P53 is mutated, accumulated LRPPRC stabilizes MDR1 mRNA, promoting chemoresistance. Gossypol-acetic acid (GAA) induces degradation of LRPPRC protein and reduces chemoresistance.\",\n      \"method\": \"RNA immunoprecipitation (RIP), mRNA stability assay, miR-34a reporter assay, GAA treatment with western blot and proliferation assays, in vivo xenograft\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RIP demonstrating direct LRPPRC-MDR1 mRNA binding, mRNA stability assay, in vivo validation, single lab\",\n      \"pmids\": [\"35484333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"LRPPRC promotes the synthesis of OXPHOS subunits by binding to RNAs encoded by mitochondrial DNA. Gossypol acetic acid (GAA) binds directly to LRPPRC and induces its rapid degradation in a ubiquitin-independent manner, suppressing OXPHOS complex synthesis.\",\n      \"method\": \"RNA binding pulldown, LC-MS target identification, GAA direct binding assay, ubiquitination assay, OXPHOS subunit expression analysis, xenograft\",\n      \"journal\": \"Journal of translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding assay for GAA-LRPPRC, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"37496051\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"LRPPRC promotes CDK4/6 inhibitor resistance in lung cancer by binding to CDK6 mRNA and increasing CDK6 mRNA stability and protein expression. CDK6 downstream effector E2F1 binds the LRPPRC promoter, forming a feedback loop; this LRPPRC-CDK6 loop facilitates G1/S transition, OXPHOS, and cancer stem cell generation.\",\n      \"method\": \"RNA immunoprecipitation (RIP) for LRPPRC-CDK6 mRNA, mRNA stability assay, promoter binding (ChIP), CDK4/6 inhibitor resistance assays in vitro and in vivo\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RIP confirming direct mRNA binding, ChIP for promoter interaction, in vivo validation, single lab\",\n      \"pmids\": [\"37452037\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SNHG17 lncRNA physically interacts with the 1035–1369 aa domain of LRPPRC protein; this interaction is required for LRPPRC to inhibit c-Myc ubiquitination and promote c-Myc stability, G1/S transition, and cell proliferation.\",\n      \"method\": \"RNA pull-down, co-immunoprecipitation, c-Myc ubiquitination assay, domain mapping, rescue experiments with LRPPRC/SNHG17 silencing\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, RNA pulldown and Co-IP but domain mapping only by deletion not mutagenesis; mechanism of LRPPRC-mediated c-Myc deubiquitination not fully resolved\",\n      \"pmids\": [\"34671012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"LRPPRC acts as an m6A reader that binds m6A-modified PD-L1 mRNA and stabilizes it posttranscriptionally in an m6A-dependent manner, increasing PD-L1 expression. LRPPRC loss downregulates PD-L1 and its m6A level in HCC cells and improves anti-tumor immunity in murine models.\",\n      \"method\": \"RNA immunoprecipitation (RIP), methylated RNA immunoprecipitation (MeRIP-qPCR), RNA stability assay, LRPPRC knockout in HCC cells and mouse models\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — RIP and MeRIP support m6A-binding, single lab, abstract does not describe mutagenesis of m6A sites to rigorously confirm reader function\",\n      \"pmids\": [\"37063837\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"LRPPRC recognizes m6A modification sites on LDHA mRNA and enhances LDHA mRNA stability, promoting glycolysis in triple-negative breast cancer. LRPPRC knockdown reduces glycolysis and increases glutaminolysis; combined LRPPRC knockdown plus glutaminase inhibition induces synthetic lethality.\",\n      \"method\": \"MeRIP-sequencing, RNA immunoprecipitation (RIP), RNA pull-down, RNA stability assay, Seahorse metabolic assay, patient-derived xenografts and organoids\",\n      \"journal\": \"Clinical and translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — MeRIP-seq plus RIP/pulldown confirming direct m6A-dependent LDHA mRNA binding, multiple orthogonal metabolic readouts, single lab\",\n      \"pmids\": [\"38372449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The LRPPRC-SLIRP complex is required for maintaining normal complex I levels in vivo; disruption of complex formation by knock-in mutations causes partial LRPPRC degradation and disappearance of SLIRP. The complex coordinates mitochondrial translation in a tissue-specific manner, and introducing an additive mtDNA mutation (m.C5024T tRNA-Ala) into Slirp knockout mice causes embryonic lethality through additive translation defects.\",\n      \"method\": \"Knock-in mice with LRPPRC-SLIRP interface mutations, SLIRP knockout mice, mitochondrial translation assays, complex I activity measurement, genetic epistasis with mtDNA mutation\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo knock-in and double-mutant genetic epistasis across two organisms/mutations, multiple molecular phenotypes\",\n      \"pmids\": [\"39087558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"USP44 recruits and stabilizes E3 ubiquitin ligase STUB1 by removing its K48-linked polyubiquitin chains at Lys30. STUB1 in turn promotes K48-linked polyubiquitination of LRPPRC at Lys453, leading to LRPPRC protein degradation and accumulation of mitochondrial ROS, facilitating apoptosis and cisplatin sensitivity in neuroblastoma.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination site mapping (K453), mass spectrometry, overexpression and knockdown with rescue experiments, in vivo tumor models\",\n      \"journal\": \"Neuro-oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — specific K453 ubiquitination site identified on LRPPRC, multiple Co-IP/rescue experiments, single lab\",\n      \"pmids\": [\"39215663\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PSMD14 deubiquitinase directly interacts with LRPPRC and inhibits its ubiquitination, thereby stabilizing LRPPRC protein. This LRPPRC stabilization inhibits autophagy through the LRPPRC/Beclin1-Bcl-2/SQSTM1 signaling pathway, promoting ovarian cancer progression.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, PSMD14 knockdown/overexpression, in vivo tumor growth and metastasis assay\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular basis of disease\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP, single lab, no specific ubiquitination sites mapped in abstract\",\n      \"pmids\": [\"36328147\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In Drosophila, loss of lrpprc2 activates the PINK1-Park (Parkin) pathway, which regulates mitochondrial dynamics by inducing degradation of the mitochondrial fusion protein Mitofusin/Marf, rather than canonical mitophagy. Bendless (a K63-linked E2 conjugase) is required for PINK1 stability and for PINK1-Park-mediated Marf degradation; loss of Bendless in lrpprc2 mutants causes photoreceptor degeneration.\",\n      \"method\": \"Unbiased genetic screen in Drosophila, lrpprc2 mutant analysis, epistasis experiments with PINK1/Park/Bendless, Mitofusin/Marf protein level assays\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic screen with epistasis in Drosophila (ortholog), multiple pathway placement experiments, single lab\",\n      \"pmids\": [\"37098042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"LRP130/LRPPRC acts as a scaffold component of a transcriptional repressor complex with PGC1α; the lncRNA GUARDIN stabilizes LRP130/PGC1α heterodimers and their occupancy at the FOXO4 promoter. Silencing LRP130 or PGC1α leads to increased FOXO4 expression, upregulation of p21, and cellular senescence.\",\n      \"method\": \"Co-immunoprecipitation of LRP130-PGC1α complex, chromatin immunoprecipitation at FOXO4 promoter, siRNA knockdown, senescence assays\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — Co-IP and ChIP supporting complex occupancy, but mechanistic detail of how LRP130 suppresses FOXO4 transcription is limited in the abstract\",\n      \"pmids\": [\"32149459\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"LRPPRC (LRP130) is a mitochondrial matrix PPR-family RNA-binding protein that, in stable complex with SLIRP, functions as a global RNA chaperone stabilizing mitochondrial mRNA secondary structures, suppressing PNPase-mediated mRNA degradation, promoting MTPAP-mediated polyadenylation, and delivering mRNAs to the mitoribosome (via contacts with mS39/mS31) for translation; loss of LRPPRC causes widespread mitochondrial mRNA destabilization, loss of polyadenylation, dyscoordinated translation of OXPHOS subunits (particularly COX1/2), ATP synthase deficiency, and compensatory mitochondrial hyperfusion and UPRmt, while outside the mitochondria LRPPRC also participates in PGC-1α-dependent nuclear transcription and, as an m6A reader, regulates stability of cytoplasmic mRNAs including MDR1 and PD-L1.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"LRPPRC (LRP130) is a metazoan-conserved, mitochondrial matrix PPR-family RNA-binding protein that governs the post-transcriptional fate of the mitochondrial transcriptome [#6, #8]. Acting as a stable heterodimer with SLIRP—formed through interaction between SLIRP's RRM domain and three PPR motifs in LRPPRC, with SLIRP reciprocally protecting LRPPRC from degradation [#2, #5]—the complex functions as a global RNA chaperone that binds mitochondrial mRNA coding sequences and remodels their secondary structure to expose sites for stabilization, polyadenylation, and translation [#1, #4]. Mechanistically, LRPPRC-SLIRP suppresses PNPase/SUV3-mediated 3' exonucleolytic decay and promotes MTPAP-dependent polyadenylation [#4], and the cryo-EM structure shows LRPPRC docking onto mitoribosomal proteins mS39 and mS31 to form a corridor that hands mRNA off to the ribosome, with COX1 and COX2 translation most dependent on this activity [#0, #13]. LRPPRC does not activate mitochondrial transcription [#7]. Loss of LRPPRC destabilizes most mtDNA-encoded mRNAs, abolishes polyadenylation, and dyscoordinates OXPHOS subunit translation, producing complex IV and ATP synthase deficiency, mitochondrial hyperpolarization and ROS, and an evolutionarily conserved compensatory program of mitochondrial hyperfusion and the mitochondrial unfolded protein response [#3, #11, #14, #17]. The A354V hypomorphic mutation underlies Leigh syndrome French-Canadian type (LSFC), reducing LRPPRC levels and selectively impairing COX I mRNA stability and translation [#12]. Outside the matrix, LRPPRC associates with PGC-1\\u03b1 as a transcriptional coactivator required for gluconeogenic and brown-fat thermogenic gene programs [#9, #19], and acts as a cytoplasmic m6A reader and mRNA-stabilizing factor whose targets include MDR1, CDK6, PD-L1, and LDHA, linking it to chemoresistance, cell-cycle progression, immune evasion, and glycolytic metabolism in cancer [#22, #24, #26, #27].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Established that LRPPRC is a bona fide RNA-binding protein localized predominantly to mitochondria, binding mitochondrial polyadenylated RNAs through a non-canonical PPR-containing domain, redirecting attention from a presumed nuclear role to mitochondrial RNA metabolism.\",\n      \"evidence\": \"In vivo RNA crosslinking/IP, in vitro RNA-binding assays, subcellular fractionation, and domain mapping\",\n      \"pmids\": [\"12832482\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define which mitochondrial transcripts are functionally regulated\", \"RNA-binding domain mapping did not resolve the full PPR architecture's contribution\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Linked LRPPRC to human disease by showing the LSFC A354V mutation reduces LRPPRC levels and selectively impairs COX I mRNA stability and translation, establishing a causal mechanism for the cytochrome c oxidase deficiency.\",\n      \"evidence\": \"Northern blot, [35S]methionine mitochondrial translation labeling, and import assays in LSFC patient cells\",\n      \"pmids\": [\"15139850\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not explain transcript selectivity for COX I\", \"Mechanism connecting reduced protein to translation defect unresolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identified a nuclear, sequence-specific transcriptional activity of LRP130 on the MDR1 and MVP promoters, the first evidence of an extramitochondrial gene-regulatory role.\",\n      \"evidence\": \"EMSA, ChIP, luciferase reporters, and siRNA/transcriptional decoys in cell lines\",\n      \"pmids\": [\"15272088\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not reconcile nuclear function with predominantly mitochondrial localization\", \"Direct DNA-binding versus cofactor recruitment not distinguished\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Placed LRP130 within the PGC-1\\u03b1 coactivator complex and showed it is required for gluconeogenic gene induction and hepatic glucose output, defining a role in metabolic transcriptional programs.\",\n      \"evidence\": \"Co-purification/MS of the PGC-1\\u03b1 complex and adenoviral RNAi in fasted mice\",\n      \"pmids\": [\"17050673\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not clarify whether this is a direct DNA-associated function or indirect\", \"Relationship to the mitochondrial RNA function unaddressed\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Extended the PGC-1\\u03b1 partnership to brown adipose tissue, showing LRP130 is required for UCP1 expression and thermogenic proton leak.\",\n      \"evidence\": \"Co-IP, knockdown in brown adipocytes, and oxygen consumption assays\",\n      \"pmids\": [\"18728005\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct versus indirect transcriptional contribution not resolved\", \"Tissue specificity mechanism unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Settled the localization debate by demonstrating LRPPRC is exclusively a mitochondrial matrix protein with a cleaved targeting sequence, constraining models of its nuclear/cytoplasmic functions.\",\n      \"evidence\": \"Subcellular fractionation and targeting-sequence bioinformatics in mammalian cells\",\n      \"pmids\": [\"20633537\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Apparent conflict with reported nuclear roles not reconciled\", \"Single-isoform claim limits explanation of dual localization\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined the core mitochondrial phenotype in vivo: LRPPRC loss collapses steady-state mRNA levels, abolishes polyadenylation, and dyscoordinates translation, establishing it as a master post-transcriptional regulator maintaining a non-translated mRNA pool.\",\n      \"evidence\": \"Conditional Lrpprc knockout mouse heart with Northern blot, translation assays, and complex analysis\",\n      \"pmids\": [\"22045337\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve molecular activities (chaperone vs. polyadenylation vs. ribosome delivery)\", \"Did not identify the partner stabilizing the complex\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Proposed that LRPPRC complexes with POLRMT to activate mitochondrial transcription, an interpretation later contradicted by more rigorous reconstitution.\",\n      \"evidence\": \"Single Co-IP, overexpression, and OXPHOS/fatty-acid oxidation assays\",\n      \"pmids\": [\"21971050\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"POLRMT interaction not confirmed and directly contradicted by PMID 23599432\", \"No in vitro reconstitution of transcriptional activation\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Mapped two mechanistic activities of the LRPPRC/SLIRP complex—suppression of PNPase/SUV3 degradation and promotion of MTPAP polyadenylation—explaining how it stabilizes mitochondrial mRNAs; a parallel study mapped COX I mRNA binding to the first 19 PPR motifs.\",\n      \"evidence\": \"In vitro polyadenylation and degradation assays, RIP, and PPR-truncation RNA-binding assays with a gene-trap mouse\",\n      \"pmids\": [\"22661577\", \"21880015\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not show how the same complex coordinates degradation suppression with translation\", \"Structural basis of mRNA handoff to the ribosome not resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Rigorously excluded a transcriptional-activation role inside mitochondria, showing no POLRMT interaction and no activation of in vitro transcription, refocusing the field on post-transcriptional function.\",\n      \"evidence\": \"Size-exclusion chromatography, multiple Co-IPs, in vitro transcription reconstitution, and transgenic/heterozygous KO mice\",\n      \"pmids\": [\"23599432\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Effect on precursor transcripts not mechanistically explained\", \"Did not address the separate nuclear PGC-1\\u03b1 transcriptional role\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Revealed conserved organellar consequences of LRPPRC loss—mitochondrial hyperfusion as a protective response to low complex IV activity—linking the molecular defect to mitochondrial dynamics.\",\n      \"evidence\": \"C. elegans mma-1 mutants and mammalian knockdown with live imaging, epistasis, and ATP measurement\",\n      \"pmids\": [\"23878239\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signaling pathway connecting OXPHOS deficiency to fusion machinery not defined\", \"Whether hyperfusion is adaptive in mammals long-term unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Reported extramitochondrial roles in autophagy control via a LRPPRC-Beclin1-Bcl-2 ternary complex, suggesting LRPPRC restrains basal autophagy.\",\n      \"evidence\": \"Reciprocal Co-IP, GFP-LC3 puncta, LC3-II/p62 westerns, and siRNA in multiple lines\",\n      \"pmids\": [\"23822101\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How a matrix protein engages cytosolic Beclin1/Bcl-2 unresolved\", \"Direct versus membrane-potential-dependent effect not separated\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Broadened the OXPHOS phenotype beyond COX to ATP synthase deficiency with subassembled complexes, hyperpolarization, and ROS, refining the bioenergetic pathology of LRPPRC loss.\",\n      \"evidence\": \"Conditional Lrpprc KO mouse heart with OXPHOS activity, membrane potential, and ROS measurements\",\n      \"pmids\": [\"24399447\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking mRNA defects to ATP synthase subassembly not detailed\", \"Tissue-specific severity not explained\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Connected LRPPRC to Parkin-mediated mitophagy under stress, positioning it on the outer membrane interface during mitochondrial turnover.\",\n      \"evidence\": \"Co-IP, fractionation, and CCCP-induced mitophagy with Parkin/Bcl-2/LC3 westerns\",\n      \"pmids\": [\"24722279\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single Co-IP/pulldown without reciprocal structural validation\", \"How a matrix protein becomes exposed on the OMM unexplained\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined the SLIRP partnership: SLIRP stabilizes LRPPRC and is required for ribosome association and efficient translation but dispensable for polyadenylation, separating the complex's activities.\",\n      \"evidence\": \"Slirp knockout mice with ribosome-fraction RNA-seq and protein-stability and polyadenylation analyses\",\n      \"pmids\": [\"26247782\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the heterodimer not yet resolved at this stage\", \"Why Slirp KO mice remain healthy despite mRNA loss unexplained\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Provided the biochemical/structural basis of LRPPRC-SLIRP heterodimerization, showing SLIRP RRM RNP1 residues are repurposed for protein-protein contact while LRPPRC carries the broad RNA-binding capacity.\",\n      \"evidence\": \"In vitro RNA-binding assays, interface mutagenesis, and biochemical complex characterization\",\n      \"pmids\": [\"27353330\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not visualize the complex on RNA or the ribosome\", \"Functional consequence of specific interface residues in vivo untested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Generalized LRPPRC-SLIRP function to a transcriptome-wide RNA chaperone that remodels mitochondrial mRNA secondary structure to expose functional sites, unifying its stabilization, polyadenylation, and translation roles.\",\n      \"evidence\": \"RNase footprinting combined with PAR-CLIP across the mitochondrial transcriptome\",\n      \"pmids\": [\"29146908\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not provide an atomic model of mRNA handoff\", \"Transcript-specific translation effects not yet structurally explained\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Delivered the structural endpoint: cryo-EM of LRPPRC-SLIRP on mRNA and the mitoribosome showing LRPPRC contacts mS39/mS31 to form an mRNA-handoff corridor, with COX1/COX2 most translation-dependent, and an in vivo study showed the complex is required for complex I maintenance with tissue-specific coordination.\",\n      \"evidence\": \"Cryo-EM with RNA-seq, metabolic labeling, ribosome profiling; plus knock-in/Slirp-KO mice and mtDNA double-mutant epistasis\",\n      \"pmids\": [\"39134711\", \"39087558\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Dynamics of repeated mRNA loading/release not captured\", \"Tissue specificity of coordination not mechanistically explained\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Established a regulated turnover network for LRPPRC, with K453 K48-ubiquitination by STUB1 (controlled upstream by USP44) and stabilization by PSMD14, coupling LRPPRC levels to ROS, apoptosis, and chemosensitivity; SIRT3 deacetylation further tunes its activity.\",\n      \"evidence\": \"Co-IP, ubiquitination site mapping, deubiquitinase/deacetylase manipulation, and in vivo tumor models\",\n      \"pmids\": [\"39215663\", \"36328147\", \"39557134\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"PSMD14 and SIRT3 studies lack mapped sites or are single-Co-IP\", \"How matrix-localized LRPPRC accesses cytosolic ubiquitin machinery unresolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined a cytoplasmic m6A-reader function for LRPPRC stabilizing oncogenic mRNAs—PD-L1, LDHA, CDK6, and MDR1—linking it to immune evasion, glycolysis, cell-cycle progression, and chemoresistance.\",\n      \"evidence\": \"MeRIP-seq/qPCR, RIP, RNA pull-down, mRNA stability and metabolic assays, with xenografts/organoids\",\n      \"pmids\": [\"37063837\", \"38372449\", \"37452037\", \"35484333\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"m6A-site mutagenesis to rigorously confirm reader function not done in several studies\", \"How an annotated matrix protein achieves cytoplasmic mRNA binding not reconciled\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How LRPPRC partitions between its established mitochondrial matrix RNA-chaperone role and its reported nuclear/cytoplasmic transcriptional and m6A-reader functions remains the central unresolved question.\",\n      \"evidence\": \"No single study reconciles exclusive matrix localization with extramitochondrial activities\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No mechanism for dual subcellular targeting\", \"Whether extramitochondrial roles reflect a minor pool or distinct isoform unknown\", \"Stoichiometry between PGC-1\\u03b1 coactivation and m6A reading undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [0, 1, 2, 3, 4, 6, 13, 22, 24, 26, 27]},\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [1, 4]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [9, 18, 19, 32]},\n      {\"term_id\": \"GO:0045182\", \"supporting_discovery_ids\": [0, 3, 5]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [6, 8]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [9, 18, 32]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [0, 1, 3, 4]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [9, 11, 19, 27]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [9, 18, 32]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [15, 30]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [12]}\n    ],\n    \"complexes\": [\n      \"LRPPRC-SLIRP complex\",\n      \"PGC-1\\u03b1 coactivator complex\"\n    ],\n    \"partners\": [\n      \"SLIRP\",\n      \"PGC-1\\u03b1\",\n      \"MTPAP\",\n      \"Beclin 1\",\n      \"Bcl-2\",\n      \"STUB1\",\n      \"PSMD14\",\n      \"MAVS\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}